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ABSTRACT 
The poor cellular uptake properties of oligonucleotides represent a major 
drawback to the antisense approach to antiviral therapy. To circumvent this problem, 
bulky lipophilic molecules such as cholesterol which interact with cell membranes 
have been bonded to the 5'-terminus of potential antisense antiviral oligonucleotides. 
A novel disulphide containing phosphotriester monomer has been synthesised which 
possesses oligonucleotide coupling efficiencies which are superior to those obtained 
from existing disulphide monomers. This dipropyl disulphide linker, which should be 
stable outside the cell but vulnerable in clisuiphide cleavage by thiols contained in the 
cell, has been introduced between the lipophlic groups and oligonucleotides. The 
oligonucleotides should thus be released froni the lipophilic groups once endocytosis 
has occurred. 
Similarly, the dipropyl disulphide linker has been introduced between a biotin 
group and an oligonucleotide. QLlantitative disuiphide cleavage can be achieved by 
the addition of dithiothrcitol. Thus ol j gon ucleotides bearing cleavable biotin moieties 
have been synthesised, eniploving a far more facile and high yielding process than the 
current meihod of choice. This approach has been extended to the synthesis of a 
novel amino functionalised disulphide linker for the production of the first cleavable 
arninolink oligonucleotides. 
Cleavage of the disuiphide bond in the dipropyl disulphide linker produces a 
propyl thiol group at the 5'-end of an oligonucleoticle. A diethyl disulphide linker has 
been synthesised which produces an ethyl thiol group on the oligonucleotide after 
disulphide cleavage. Under basic conditions, the oligonucleotide can eliminate 
mercaptoethanol to give a 5'-phosphate group. Thus a simple, high-yielding method 
for the synthesis of terniinal thiol and terminal phosphate functionalised 
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ABBREVIATIONS 
A adenine 
AIDS acquired immune deficiency syndrome 
AZT 3tazido2,3dideoxythymidine 
C cytosine 
C2SS diethyldisuiphide group 
C16 hexadecyl group 
C35 1 ,2-di-O-hexadecylglyceryl group 
C35-C6 arninohexyl linked I ,2-di-O-hexadecylglyceryl group 
Chol cholesteryl group 
Chol-C6 aminohexyl linked cholesteryl group 
CPG controlled pore glass 
dA 2'-deoxyadenosine 
DBU 1 ,8-diazabicycloj5.4.Ojundec-7-ene 
dC 2-deoxycytidine 
DCC dicyclocarbodiimide 
DEC 1 -(3-dimethylaniinopropyl)-3-ethylcarbodiimide 
dG 2-deoxyguanos oe. 






FAB fast atom bombardment 
FMOC 9-fluorenylmethoxycarbonyl 
G guanine 
HEG hexaethyieneglycol group 
HIV human immunodeficiency virus 
HSV1 herpes simplex virus 1 
IAF 5-iodoacetamidofluorescein 
MMTr 4-monomethoxytrityl 
mRNA messenger RNA 
MSNT 1- (mesitylene-2-sulphonyl)-3-nitro- 1 ,2,4-triazole 
NAP nucleic acids purification 
NIHS-SS-Biotin sulphosuccinimidyl-2-(hiotinamido)ethyl- 1,3'-dithiopropionate 
OD optical density 
PCR polymerase chain reaction 
PVC1 pivaloyl chloride 
SPDP N-succinimidyl-3-(2-pyridyldithio)propioflate 




TCA trichioroacetic acid 
TEA triethylamine 
TEAB triethylammonium bicarbonate 
TETD tetraethylthiuram disulphide 
THF tetrahydrofuran 
THP tetrahydropyranyl 
tic thin layer chromatography 
Tosyl p-toluenesulphonyl 
TPSC1 triisopropylbenzene sulponyl chloride 
tRNA transfer RNA 
U uracil 
I INTRODUCTION 
1.1 General Introduction to DNA Chemistry 
Much of the knowledge we possess today concerning the structure and function 
of DNA is taken for granted. However, most of the important breakthroughs in DNA 
chemistry have occurred relatively recently. In 1933, Thannhauser and Klein' first 
obtained the four deoxyribonucleotide components of DNA. The structures were 
confirmed by the first dinucleotide synthesis by Todd  in 1955, following the 
























2 '-deoxy-D-ribofuranose 	D-ribofuranose 
Figure 1.1 
In 1953, Watson and Crick '3  discovered the complementary double-helical structure 
of DNA and with it came understanding of the process of replication. Once the 
genetic code had been elucidated ,46 modern DNA chemistry began. 
All DNA nucleotides are composed of a phosphate, a deoxyribose sugar and 
one of four main nitrogen heterocyclic bases (Figure 1.1): adenine (A), guanine (G), 
- 
cytosine (C) and thymine (T). In RNA nucleotides, the pyrimidine, uracil (U), and the 
0-ribose sugar occur instead of thyrnine and 2'-deoxyribose,. The nucleosides are linked 
by 3' to 5' phosphodiester groups with the bases attached to the sugar at the 1' 
position in the (3-configuration (Figure 1.2). 
Figure 1.2 
Where B = A, G, C or T 
O=P—O-
0 
The high nitrogen and oxygen content of the heterocyclic bases provides them 
with considerable potential to font hydrogen bonds and ionisable phosphate groups 
engender them soluble in aqueous rather than organic solvents. The hydrogen bonds 
between thymidine and adenosine and guanosine and cytidine (Figure 1.3) stabilise 
the so called Watson-Crick base pairs .3  The specific base pairs formed are mainly 
responsible for holding together the double helical structure of DNA as an antiparaJiel 
duplex. Although many conformations of DNA have been identified ,79 the most 
important are the right handed double helices of A-DNA and B-DNA. Duplex 
stability can be measured in terms of the melting temperature, the temperature at 
which 50% of the duplex has denatured. 
11 
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Figure 1.3 : Watson-Crick Base Pairs 
The primary function of DNA is to store the genetic code for each particular 
organism. By the process of replication, DNA is copied so that each daughter cell has 
its full complement of DNA after cell division. The transcription of DNA leads to the 
formation of a complementary strand of messenger RNA (mRNA) which is 
transported to the ribozomes where protein synthesis occurs. Transfer RNA (tRNA), 
a short strand of RNA less than 100 nucleotides in length, carries individual amino 
acids to the ribozonìe where they fon-n peptides and proteins of sequence determined 
by the mRNA. Every amino acid is coded for by a codon, a specific, 3 base, non-
overlapping triplet, on the rnRNA. Thus RNA plays an essential role in the 
functioning of the cell. 
4 
1.2 Chemical Synthesis of Oligonucleotides 
The demand for a rapid, high yielding process for the synthesis of short strands 
of DNA, known as oligodeoxyribonucleotides or, more generally, oligonucleotides, is 
enormous. They are used as primers in DNA sequencing or amplification, mutagenic 
agents to alter the sequence of genes, probes or labels in DNA detection, isolation and 
diagnostics and as potential therapeutics. Any chemical process for oligonucleotide 
synthesis has to be compatible with the numerous functional groups present and the 
sensitivity of certain parts of the molecule (e.g. the acid lability of the glycosidic sugar 
to base bonds). The basic strategy in oligonucleotide synthesis is to form a 
phosphodiester bond between the 3'-hydroxyl group of one nucleoside and the 5'-
hydroxyl group of the other. 
1.2.1 Solid Phase Synthesis 
The breakthrough of Merrifield")  in the synthesis of peptides on a solid support 
led to a similar technology being applied to oligonucleotide synthesis." A nucleoside 
is bound, usually through the 3'-hydroxyl group, via a linker to an insoluble solid 
support to allow 3' to 5 chain extension. A sequential addition of monomers is 
carried out until the desired oligonucleotide is obtained which is then cleaved from the 
solid support. Controlled pore glass (CPG) beads, 
12  rigid and non-swellable, have 
proved the most useful solid support. These are usually derivatised with aminopropyl 
groups to extend the active sites away from the solid surface and ensure accessibility 
of the growing DNA chain to all reagents. The CPG is usually linked to the 
oligonucleotide by a succinyl ester group. The succinyl linkage is cleaved by base 
hydrolysis using ammonium hydroxide. 
In solid phase methodology, all reagents employed in chain assembly are 
removed simply by washing the CPG and filtering. As a result, all reagents can be 
used in excess and yields are high. There is no need for purification steps during chain 
assembly and this allows more rapid syntheses. In the 1980s, solid phase synthesis 
was automated and the phosphite triester approach is now the routine method of 
oligonucleotide synthesis. The primary drawback of solid phase synthesis is the 
limitations of scale; the CPG resin can only contain a limited number of active sites, 
between 10 and 60tmolg' loading, above which the individual growing chains are 
susceptible to steric crowding. This is currently an area of active research. 
1.2.2 Protecting Groups 
The exocyclic amino groups of the A, G and C bases must be protected during 
oligonucleotide synthesis to prevent undesirable side-reactions. The protecting 
groups have to be stable throughout oligonucleotide chain assembly, but must be 
cleavable once the synthesis is complete i.e. they are semi-permanent protecting 
groups. Khorana'3"4 introduced acyl protecting groups in the 1960s and indeed this 
type of base protection is still the most popular. The benzoyl group is used to protect 
both adenine and cytosine and the isobutyiyl group to protect guanine (Figure 1.4). 
Thymine requires no protection as it does not contain an exocyclic amino group. The 













The protecting group of choice for the 5-hydroxyl position of the deoxyribose 
sugar, a temporary protecting group, is the 4,4'-dimethoxytrityl (DMTr) group 
(Figure 1.4), again introduced by Khorana.15 It is sufficiently acid labile that an acid 
such as trichioroacetic can rapidly remove it. The 4,4'-dimethoxytrityl cation thus 
released has a bright orange colour (495nm) which can be used to determine the 
success of the coupling reaction. 
1.2.3 Methods of Oligonucleotide Synthesis 
1.2.3.1 Phosphodiester Method 
The classical synthetic method, the phosphodiester approach, was pioneered by 
Khorana and colleagues. 16,17  The method involves the coupling of a 5'-protected 
deoxynucleoside with a 3-protected deoxynucleoside 5'-phosphomonoester (Figure 
1.5). The condensing agent, initially dicyclohexylcarbodiimide (DCC 
)18  but more 
recently 	tri isopropyl benzenesul phony l 	chloride 	(TPSC1),19 	activates 	the 
phosphomonoester. The 3-protecting group of choice is commonly acetyl or a silicon 
derivative and is therefore removed by alkali or fluoride ions respectively, allowing a 
5' to 3' chain extension. The 5-protecting group used by Khorana was 4- 
monomethoxytrityl (R = MMTr). 
However, a major drawback in this method is the susceptibility of the 
unprotected phosphate group in the product to further attack by activated 
phosphomonoester. An aqueous work-up is required to partly reverse this process 
but poor reaction yields, lengthy coupling times and extensive purification 
requirements result. Thus the synthesis of long oligonucleotides is an extremely time 
consuming and low yielding procedure. 
The coupling of the 5'-hydroxyl group of a nucleoside to a solid support 











Figure 1.5: The Phosphosdiester Approach 
1.2.3.2 Phosphotriester Method 
The phosphotriester approac1120  was investigated initially in the 1950s2 but it 
was not until the early 1970s21 '22  when the process was further developed that it began 
to supercede the phosphodiester method. The weakness of the phosphodiester 
coupling is avoided by the introduction of a phosphate protecting group. Initial 
protecting groups such as -cyanoethy1" 23 and 2,2,2-trichloroethyl,24 have since been 
replaced by aryl groups, the 2-chiorophenyl group in particular. 
25-28  The aryl esters 
can be removed by treatment with certain oximes29 or prolonged treatment with 
ide.3°  The condensing agent has similarly developed from ammonium hydrox  
arylsulphonyltriazoles3' and arylsulphonyltetrazoles32  to the current agent of choice, 
1 -(mesitylene-2-sulphonyl)-3-nitro- I ,2,4-triazole (MSNT).33 MSNT activates the 3'-
deoxynucleoside phosphodiester in the coupling reaction (Figure 1.6). The 2 and 6 
methyl groups of the mesitylene ring provide steric hindrance at the sulphur to ensure 
condensation at phosphorus. Often N-methylimidazole is added to enhance the 
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Figure 1.6 : The Phospizotriester Approach 
It acts as a nucleophilic catalyst, forming an N-methylimidazolium phosphodiester 
with the N-methylimidazole a superior leaving group. The coupling reaction is 
normally carried out in pyridine with the triethylammonium salt of the nucleotide 
monomer. Chain extension is in the 3' to 5' direction. 
The coupling yields are limited to 97-98% due to a competing 5-hydroxyl 
suiphonation reaction by the MSNT. The vulnerability of the 0-6 position of 
deoxyguanosine and the 0-4 position of thymidine to nitrotriazole substitution leads 
to a further side reaction unless these groups are protected. Thus oligonucleotide 
length is restricted to 40-50 residues. 
Solid phase synthesis was successfully carried out using phosphotriester 
chemistry34 (Figure 1.6, R = solid support) but this has largely been superceded by 
phosphite ti-jester solid phase synthesis due to the superior coupling yields and faster 
coupling tunes of the latter. However, phosphotriester chemistry does have its 
advantages: the stability and ease of handling of the monomers; the removal of small 
quantities of moisture in the coupling step by MSNT; the need for only slight excess 
of monomer; and the viability of the method for solution phase synthesis: the latter 
two being particularly advantageous for large scale synthesis. 
1.2.3.3 Phosphite Triester Method 
The value of trivalent phosphorus in oligonucleotide synthesis was first realized 
by Letsinger,35 using chiorophosphites, but it was the introduction of the more stable 
phosphoramidites by Caruthers36  which brought the real breakthrough. The initial 
dimethylamino groups were replaced by others37 such as N-morpholino and, in 
particular, N,N-diisopropyl. The advent of solid phase synthesis has made the 
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Figure 1.7 : The Phosphite Triester Approach 
IF 
The key step in the method is the highly efficient coupling between the free 5'-
hydroxyl group of the support bound oligonucleotide and the 5'-protected 
phosphoramidite monomer in solution (Figure 1.7). The nitrogen atom of the 
phosphoramidite group is protonated by a weak acid (tetrazole) which leaves the 
DMTr group untouched. Coupling is followed immediately by a capping step using 
acetic anhydride and N-methylirnidazole to block any unreacted 5'-hydroxyl groups in 
order to simplify purification. The capping step also reverses any undesirable 
phosphitylation of the 0-6 position of guanine. Iodine oxidation produces the 
phosphotriester and chain extension can continue. Each synthesis cycle can take as 
little as 5 minutes. Once oligonucleotide synthesis is complete and solid support 
cleavage has occurred, the phosphate protecting group of choice, f3-cyanoethyl, is 
removed with ammonium hydroxide treatment at the same time as removal of the base 
protecting groups. 
As a consequence of the high coupling yields (>98%) and rapid coupling times, 
oligonucleotides of up to 100 residues in length can be made with ease. The only 
minor drawback is the susceptibility of P(III) reagents to oxidation and hydrolysis on 
storage. 
1.2.3.4 H-Phosphonate Method 
As with the phosphotriester method, H-phosphonate chemistry has its origins 
with Todd in the 1950s39 but has only recently resurfaced 40'4' as a viable method for 
oligonucleotide synthesis. Again, it is usually employed on a solid support with a 3' to 
5' chain extension (Figure 1.8). The coupling reaction is activated by a hindered acyl 
chloride such as pivaloyl chloride (PVC1) and the resultant H-phosphonate diester is 
relatively stable both to further coupling and to acid catalysed cleavage. Hence no 
phosphate protecting groups are required and iodine oxidation only occurs once as 
























Figure 1.8 : The H-Phosphonate Approach 
In addition, coupling is rapid and efficient and the rigorously anhydrous conditions 
necessary in the phosphoramidite approach are not essential. However, the coupling 
efficiency is not as high as in the phosphoramidite approach due to a side reaction; in 
the presence of the activating agent, the H-phosphonate monomer tends to dimerise 
to form a symmetrical phosphite anhydride. 
13 
1.3 Antisense Oligonucleotides 
1.3.1 The Antisense Theory 
As protein synthesis in cells is the result of two basic steps, transcription and 
translation, the basic antisense method 
42,41  to inhibit protein synthesis is 
straightforward: introduce a synthetic DNA molecule of base sequence 
complementary to that of the n1RNA to be inhibited. The ribozomes are prevented 
from reading the genetic code from the mRNA:DNA hybrid duplex and the action of 
RNaseH,44  an RNA digesting enzyme involved in DNA replication but also present in 
the cytoplasm, digests the mRNA. It is known that antisense regulation of gene 
expression exists as a naturally occurring mechanism in cells.45  
An immediate application of this theory is the selective inhibition of viral protein 
synthesis. Given the DNA sequence of a particular virus, readily obtainable using 
standard procedures, an oligonucleotide drug molecule can be designed. If an 
accessible region of the viral gene is chosen and the oligonucleotide is of sufficient 
length to ensure selectivity, it should have enormous advantages over small molecule 
drugs. 
Particular attention has been focused on retroviruses such as the human 
immunodeficiency virus (HIV),46 the retrovirus responsible for acquired immune 
deficiency syndrome (AIDS). Anti-HIV treatment to date has focused on 3t-azido-
2,3'-dideoxvthymidine (AZT)47 and other dideoxynucleosides which operate as 
reverse tran scriptasechain terminatocs However, they are unsatisfactory antiviral 
agents due to toxicity and the resistance of certain viral strains. 
Retroviruses enter the host cell in RNA form and the RNA is copied into viral 
DNA by the action of the viral DNA polymerase, reverse transcriptase. The viral 
DNA molecules are integrated into the nuclear DNA of the host cell and normal 
cellular transcription and translation lead to the synthesis of viral protein and the virus 
14 
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Figure 1.9 : Antisense Viral Inhibition 
Early work in this field 41,49  was carried out on the Rous sarcoma virus using 
complementary 13mer (13 base pairs in length) oligonucleotides. Despite the strictly 
limited success of unmodified oligonucleotides,5053 the antisense theory was validated. 
Problems arose largely due to the instability of oligonucleotides in cells. Single 
stranded DNA is degraded by DNase enzymes present in serum and cytoplasm. 54  In 
order to prevent this, chemically modified oligonucleotides are now used. 
15 
1.3.2 Modified Synthetic Antisense Otigoriucleotides 
Clearly, any modification introduced into the antisense DNA molecule must not 
greatly reduce the stability of the DNA:RNA hybrid duplex which is the substrate for 
RNaseH.55'56 The molecule must also possess low toxicity. 
1.3.2.1 Phosphorothioates 
Probably the most widely used of all DNA analogues are phosphorothioate 
oligonucleotides in which one of the non-bridging oxygen atoms in each 
intemucleotide phosphate linkage is replaced by a sulphur atom. Although some 
depression of melting temperature Occurs, 
57,58  considerably improved nuclease 
resistance is observed and potent antisense effects in H1V5962 and other systems6365  
have been recorded. However, activity was initially only observed in de novo 
systems59 and the unexpectedly high activity of an oligo dC phosphorothioate 
(SdC28) revealed a second, non-sequence dependent mode of inhibition which was 
shown to arise from interaction of the oligonucleotide with HIV reverse 
transcriptase.66 
Despite the complexities of HIV as a retrovirus, two regulatory genes, tat and 
rev (art/trs), 7  both thought to be essential for viral replication, have been identified. 
Clearly, inhibition of either of the genes would inhibit virus assembly. A 28mer 
phosphorothioate, SRev d(TCG TCG CTG TCT CCG CTT CTT CCT GCC A), 
complementary to a region from the 2nd to the 29th bases of the rev gene showed 
significant inhibition of rev protein synthesis in chronically infected cells.61 This led to 
the drastic reduction of unspliced viral rnRNA transcripts since the rev gene regulates 
the expression of viral proteins by influencing the splicing of the viral mRNA. Other 
phosphorothioates of similar length targeted in the same region showed lesser degrees 
of HIV inhibition. The absence of significant activity using phosphorothioate 28mer 
of random sequence and an antisense sequence with unmodified normal 
16 
phosphodiester linkages showed that sequence specificity and nuclease resistance are 
essential for viral inhibition. 
1.3.2.2 Phosphorothioate Oil gonucleotide Synthesis 
The synthesis of phosphorothioate oligonucleotides is most commonly achieved 
in the phosphoramidite method by replacing the oxidation step in each synthesis cycle 
by a sulphurisation step. This is a matter of simply replacing the iodine/pyridine bottle 
on the automated DNA synthesiser by the sulphurisation reagent and allowing a 
longer reaction time. Tetraethylthiurarn disulphide (TETD)68 has now replaced 
elemental sulphur in carbon disulphide as the reagent of choice, achieving 
sulphurisation in comparable efficiency to iodine oxidation in a 15 minute step 
(Figure 1.10). The undesirable Arbuzov side reaction (B), caused by dithiocarbamate 
attack on the cyanoethyl group is blocked by the steric bulk of either the phosphite or 
thiuram substituents. The desired pathway (A) predominates almost exclusively. 
Phosphoi-othioates can also be synthesised using phosphotriester chemistry. 
However, the process is somewhat more laborious because the coupling reaction 
analogous to the standard phosphotriester chemistry using 2-
chlorophenylphosphorodichloridothioate69'7° as the phosphorylating reagent does not 
work .7 A leaving group superior to the chloride anion is required for the coupling 
step and attention has focused on l-hydroxybenzotriazole72 and analogues,73 the most 
successful of these being the 1-hydroxy-6-trifluoromethylbenzotriazoyl group (Figure 
iji).74,75 
 
The H-phosphonate method is employed to make complete phosphorothioates 
with the advantage of requiring only a single sulphurisation step at the end of the solid 
phase oligonucleotide synthesis. However, it cannot be used to make mixed 
phosphorothioate/phosphodiester ol igonucleotides because phosphorothioate diesters 
are converted by iodine/water to phosphodiesters. 
17 




















Figure 1.10 Suipli urisation of the Phosphorainidite 
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Figure 1.11 : The Synthesis of the Pliosplioiylating Reagent 
in the Plwspliotriester route to Ph.osphorothioates 
In all the above methods, a mixture of R and S enantiorners at the phosphorus 
atom is formed (Figure 1.12) and efficient, reliable processes for the synthesis of 
chirally pure phosphorothioates are still being sought. 76 
Figure 1.12 Phosphorothioute Stereochemistry 
9 
1.3.2.3 Other Backbone Modifications 
Phosphorodithioates (Figure 1.13),77 where both non-bridging oxygen atoms in 
the phosphate linkage are replaced by sulphur, possess an achiral phosphorus centre. 
However, the antisense activity of these compound 
S7' appeared to be less promising 
than for the phosphorothioate analogues. 
Oligonucleotide methyiphosphonates (Figure 1.13),
79 
 with a phosphate oxygen 
atom replaced by a methyl group, were among those early analogues which heralded 
the recent rapid expansion in the numbers of backbone modified oligonucleotides. 
They have an uncharged backbone and therefore have increased hydrophobicity 
leading to improved cell membrane permeabilility properties, nuclease stablility and 
duplex stability relative to phosphorothioates.58 They have been tested for activity 
against HI V,8° herpes simplex virus I (HSVI)8 ' and other viruses.63'82 However, the 
chirality problem still exists and as hybrids of these analogues with RNA are not 
substrates for RNaseH,5556 unlike phosphorothioates, antisense effects are reduced. 
In addition these analogues have poor aqueous solubility. 
5-Amino nucleosides have long been known" and phosphoramidate 
oligonucleotides (Figure 1.13), with a bridging phosphate oxygen atom replaced by 
nitrogen, have been known for almost as long. 14  However, with the advent of the 
antisense method, superior synthetic procedures have been developed. 85'86 These 
analogues have an additional property: selective acidic cleavage of the oligonucleotide 
at the P-N bond is possible. Early hybridisation work 
87  suggested an increase in 
melting temperature for an oligonucleotide with a single 3'-terminal amino group, 
although 5'-terminal and internal phosphoramidates appear to destabilise the duplex. 
Enzymatic oligonucleotide degradation in cells appears to be mostly due to 3' to 
5' exonucleases although endonucleases and 5' to 3' exonucleases are also present. 
Thus nuclease stabilty can be enhanced simply by introducing a modification at the 3' 
end of the oligonucleotide. 88 Examples of this are intercalators such as acridine 
(Figure 1.13)89  which also facilitates cellular uptake and provides additional binding 
20 
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energy by inserting (intercalating) between the base pairs of the oligonucleotide and 
its complementary sequence. It has also been suggested that antiviral activity of 
intercalator bound oligonucleotides can occur as a result of triple-helix formation 
between the antisense strand and viral DNA.9°  
Another class of synthetic antisense oligonucleotide is u-anomeric DNA 
(Figure 1.13) in which the 3-linkage between the nucleotide sugar and base is 
replaced by the unnatural a-linkage. Nuclease stability is greatly increased and in 
certain sequences these analogues form hybrids with RNA which are more stable than 
the f3-oligonucleotides.9' Unfortunately they are extremely expensive to synthesise. 










Figure 1.13 : Examples of Backbone Modifications 
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Nuclease stability may also be conferred on an oligonucleotide by introducing 
modified bases, pyrimidines in particular, 
93 without adversely affecting duplex 
stability. It is claimed that modifications at the 5 or 6 positions of cytidine or 
thymidine block a nuclease binding site. In an attempt to achieve irreversible 
inactivation of the target oligonucleotide by cross-linking across the major groove, all 
alkylating electrophile, the 3-(iodoacetomido)propyl group, was joined to the 5 
position of a thymidine.94 
Alterations to the sugar ring include the substitution of hexose for pentose 
sugars 95  and a 4'-thio group to replace the sugar bridging oxygen. 
96  Other more 
radical backbone modifications involve completely replacing the phosphate 
internucleotide linkage. 	Examples of novel linkages include the 
methylhydroxylarnine,97 carboximide,9' formacetal99 and guanidine100 groups. In 
addition to being nuclease resistant, oligonucleotides containing these modifications 
show surprisingly little depression of melting temperature. 
An interesting recent development has been to combine peptide-like backbones 
with nucleic acid bases. The idea originally appeared some years ago10' but it has 
attracted fresh interest due to the extremely high duplex stability discovered for a 
particular peptide nucleic acid analogue. 
102  Melting temperatures are considerably 
higher than the equivalent unmodified hybrids although questions have arisen over the 
sequence specificity of such molecules. 
1.3.3 Oligonucleotides Linked to Transport Agents 
Oligonucleotides are large, polyanionic molecules which therefore have poor 
cell permeability properties although the exact nature of oligonucleotide/phospholipid 
membrane interactions is unclear.'03 	In the case of the phosphorothioate 
oligonucleotide, SRev, the dose required to achieve significant anti-HIV effects is 
quite high (-25iM). By linking the antisense oligonucleotide to transport agents, 
22 
largely bulky, lipophilic molecules, uptake and thus antiviral activity might be 
enhanced. 
Cholesterol covalently linked to oligonucleotides has been the most widely 
investigated transport agent. The coupling reaction has been performed using 
phosphoramidite cholesterol monomers 
104,105 or using H-phosphonate chemistry '°6"°7  
or post-synthetically via a urethane linker.' 
05 Having a 3-terminal cholesterol in order 
to engender greater nuclease stability,8" has been achieved via a carboxyaminoethyl 
linker,"'" coupling to the N-6 position of a 3-adenosine,'09 post synthetically' 10 or 
through attachments to the solid support via a variety of different groups: solketal,'°4 
hydroxy-L-proline,"' pyrrolidinylbuta tied ioate" or aminoglycerol.105 Cholesterol can 
be linked to an oligonucleotide via a disulphide group using H-phosphonate 
chemistry' 2 or by a disulphide exchange reaction." 
3,114 
The coupling of a cholesterol phosphoramidite directly to SRev presents a new 
problem. 104  The normal cholesterol phosphoramidite coupling produces a phosphite 
diester linkage between the cholesterol group and SRev; sulphurisation of which with 
TETD failed due to extreme steric hindrance. By reacting cholesteryl chioroformate 
[1] with 6-aminohexan- 1 -ol (Figure 1.14), a carbamate linked hexyl spacer with an 
available hydroxyl group [2] was synthesised. The resulting unhindered monomer [3], 
when coupled to SRev, suiphurised smoothly. 
Long, alkyl chains have been covalently linked to oligonucleotides. The 1,2-di-
0-hexadecyiglyceryl group has been synthesised' 
15  from allyl alcohol (Figure 1.15). 
Tetrahydropyranyl (THP) protection of the hydroxyl was followed by oxidation with 
potassium permanganate.' 6  Subsequent reaction with hexadecyl mesylat&'7 and 
deprotection"' led to the product [4].  This was coupled to the oligonucleotide 5'-
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The hexadecyl phosphoramidite monomer [5] (Figure 1.16) was coupled to both 5'- 
and 3'-termini of different oligonucleotides.104 	Similarly, 5'-octadecyl104 and 







DMTrO\ 0 CN 
[5] 
Figure 1.16 
Other less common groups used as transport agents include poly-L-lysine,'22 
vitamin E,123 adamantyl'°4 and phenazinium.'1° 
In some assay systems, lipophilic modified oligonucleotides show increased 
antiviral activity 	and 	this 	is assumed to be the direct result of cellular uptake 
changes,' 
06-108,112-114 
	although the effect seems to be non-sequence dependent in 
several cases. 106,107,112 
Although oligonucleotide duplex stability has been reported to be adversely 
influenced by the presence of a teniiinal lipophilic group,108"12 or not influenced much 
at all,104 it has more generally been the case that the effects are favourable.88'105"1'113  
More than one cholesterol group in a single oligonucleotide engenders notable extra 
stability in both duplexes and triplexes,105  presumbly through inter-cholesterol 
hydrophobic interactions. 
26 
1.4 Functional Groups in Oligonucleotides 
1.4.1 Disulphides in Oligonucleotides 
3'-Alkyl disulphides have been introduced into oligonucleotides using modified 
solid supports (Figure 1.17).124127  Zuckerman et al 
124  phosphorylated a 5'-protected 
nucleoside at the 3'-position then introduced the 3,3'-dithiodipropanol group [6] or 
alternatively, for thymidine, reacted 2,3-anhydrothymidine with either 1,3-
propanedithiol or 1 ,6-hexanedithiol then coupled with S- (2-thiopyridyl)-2-
mercaptoethanol to introduce the disulphide [7].  More simply, Gupta et al, 
121  initially 
coupled S-(2-thio-5-nitropyridyl)-2-mercaptoethanol onto the solid support, then, by 
a disulphide exchange reaction, introduced the 4,4-dimethoxytritylated n-
mercaptoalkane of length C2, C3 or C6. The most facile approach was that of 
Asseline et al 126 in which 1-(4,4-dimethoxytrityl)-2,2'-dithiodiethanol [8] was 
introduced directly onto the Fractosil 50() solid support, in development of the 
octaethyleneglycol work of Bonfils and Thuong.'27 In all cases, detritylation allowed 
automated oligonucleotide synthesis with every subsequent nucleotide coupling with 
standard efficiency. 
Cleavage of disulphides is routinely carried out with an excess of dithiothreitol 
(DTT)'28 above pH7. For the C3 and C6 alkyl disulphide linkers, a 3'-thiol group was 
obtained. In the case of the C2 linker, however, DTT treatment led to a 3-phosphate 
by elimination of mercaptoethanol (Figure L18).' 25' 126 Asseline et a!126 extended this 
idea to make 3-terminal phosphorothioates and aminoalkyl derivatives. 
A 3'-disulphide group has also been introduced post-synthetically by reacting an 
oligonucleotide bearing a 3-amino functionality on a modified cytidine residue, with 
dithio-bis-propionyl-N-hydroxysuccinirnide [9]129 or by reacting N-acetyl-N-(p-
glycoxylbenzoyl)cystamine [10] with a 3-deprotected guanosine residue on the 
oligonucleotide (Figure 1.19).' 3° Disulphide cleavage and a disulphide exchange 
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Figure 1.19 
Oligonucleotides containing 5'-disulphides are less common. By reacting a 5'- 
amino 	functionalised 	ol igon ucleotide 	with 	N-succinimidyl-3-(2- 
pyridyldithio)propionate (SPDP) [11] (Figure 1.19), a 5'-disulphide hence a 5'-thiol 
was obtained. 13' The reaction of 3-thiocholesterol with dipyridyl disulphide [12] 
(Figure 1.19) gave a cholesterol disulphide which, by a disulphide exchange reaction 
with a cystamine oligonucleotide derivative, led to a cholesterol-disulphide 
oligonucleotide.113 This has also been achieved more simply on solid phase via H-
phosphonate chemistry in which 2-(4,4'-dimethoxytrityl)-2-hydroxyethyl disulphide or 
mono[2-(4,4'-dimethoxytrityl)] (hydroxyethoxy )ethyl 	disulphide 	hydrogen 
30 
phosphonate monomers were incorporated into the 5' position of a d(CAGTGATT) 
sequence. Subsequent coupling of dT and dC monomers and a cholesterol hydrogen-
phosphonate monomer led to the target oligonucleotide (Figure 1.20).h12 
0 
11 
TTAGTGAC—R-SS-R-CT0 — P... 
/ 0 
0 - 
where R = CH2CH2 or CH2CH20CH2CH2 
Figure 1.20 
A disulphide has been introduced between a biotin group and an oligonucleotide 
(Figure 1.21)132  by modifying the 5 position of a 2'-deoxyuridine 5-triphosphate [13]. 
Reaction with mercury (II) acetate introduced a mercury atom into the 5 position 
which was substituted with an allylamine group. 	This then reacted with 
sulphosucciniinidyl-2- (biotinamido)ethyl- I ,3'-dithiopropionate (NHS-SS-Biotin) [14] 
to introduce the biotin. The modified nucleoside triphosphate [15] was then 
incorporated into an oligonucleotide by nick translation. 
Oligonucleotide blocks have been combined through a disulphide formed 
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Figure 1.21 Cleavable Biotin Monomer 132 
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1.4.2 Terminal Thiol Groups 
Disulphides are primarily introduced into oligonucleotides as a potential source 
of terminal thiols.'24 '27 '29"3' Direct solid phase routes to thiols (Figure 1.22) are 
limited in number. 	Connolly' 
14  coupled an alkyl linked tritylated thiol 
phosphoramidite monomer [16] at the 5'-end of an oligonucleotide. Sproat et al,' 35 
phosphitylated a 5-tritylated thiol nucleoside [17] and coupled this to the 5'-end of an 
oligonucleotide. In both cases, cleavage of the trityl group was achieved with silver 
ions which were then removed by precipitation with DTT. Again, conversion of the 
C2 linked thiol group to the phosphate by elimination of mercaptoethanol was 
observed. 116  The process was extended to H-phosphonate chemistry with the 
standard oxidation step to form phosphodiester linkages. This was carried out before 
additon of the tritylated thiol H-phosphonate monomer which had to be oxidised 
under special conditions to avoid thiol loss.137 Finally, the reaction of a 5-amino 
functionalised oligonucleotide with a cysteine derivative led to an alkyl linked thiol. '38 
Reaction of a thiol with a suitable thiol specific reporter group is a 
straightforward means of confirming its identity. 5 -lodoacetamidofluorescein (IAF) 





















Figure 1.23: 5-lodoacetainidofluorescein 
1.4.3 Terminal Phosphate Groups 
5'-Terminal phosphate groups can be introduced enzymatically 
140  but several 
procedures have been developed for their introduction during simple solid phase 
coupling reactions. To be compatible with phosphoramidite chemistry, a second 
phosphate protecting group is all that is required, which must be easily cleavable once 
oligonucleotide synthesis is complete. A second f3-cyanoethyl group or alternatively a 
p-nitrophenvlethyl group have been used both of which are cleaved by strong base 
after oligonucleotide purification. 14 ' However, the reagent of choice is the (2-
cyanoethyl)- 2- [2'-(4,4-dimethoxytrityl)ethylsulphonyl)] ethoxy-N,N- 
diisopropylphosphoramidite monomer 
142,143  [19] (Figure 1.24). 
0 	 Y 
DMTrO Q— \ P  
0 	 \ACN 
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It possesses a DMTr group to permit measurement of coupling efficiency and the 
phosphate protecting group is readily cleaved by base under standard oligonucleotide 
deprotection conditions. Furthermore, with 13-elimination possible at either end of the 
molecule, it can be used to synthesise both 5'- and 3'-terminal phosphates and is 
superior to other solid support modification methods. 
144,145  Coupling onto the 3t 
support bound nucleotide allows chain extension through the other hydroxyl function 
present with final deprotection cleaving both protecting group and the 3'-nucleotide. 
Similarly, by replacing the oxidation step with a suiphurisation step, 3'- and 5'-terminal 
phosphorothioates can be synthesised. The only drawback to the monomer occurs 
during oligonucleotide purification. 	In reverse phase high performance liquid 
chromatography (HPLC), the standard method of oligonucleotide purification, the 
molecules elute in reverse order of lipophilicity. Without a hydrophobic group such 
as p-nitrophenylethyl,'4 ' it is difficult to separate the terminal phosphate 
oligonucleotide from the unphosphorylated failure sequences. 
1.4.4 Terminal Amino Groups 
The amino group is an extremely useful functional group for the terminus of an 
oligonucleotide. It can be reacted with electrophiles for the synthesis of further 
derivatives and is far more reactive than the normal terminal hydroxyl group. There 
are many methods for the attachment of such a functionality varying from post-
synthetic acdition by activation of the 5'-hydroxyl 146  or the 5'-phosphate 
147  groups 
then addition of a diaminoalkyl reagent, solid phase triester chemistry using 
aminoalkyl monomers 141,149  or H-phosphonate chemistry. 
137  However, the most 
useful method is direct attachment during phosphoramidite solid phase synthesis. In 
this way it is possible to add various protected aminoalkyl monomers,'37 in particular, 
the N-trifluoroacetyl-2-aniinoethanol monomer in which the trifluoroacetyl protecting 
group is removed during extended ammonia treatment. 	The extension of this to the 
aminohexanol equivalent, the 'aminolink 2' monomer [20] (Figure 1.25) is particularly 
36 
effective. '51 	The 9-fluorenylmethoxycarbonyl (FMOC) protected aminoethanol 
analogue has also been made. 112 
0 	
. ~~ 





Figure 1.25: 'Aininolink 2' Monomer 151 
However, once the aminolink and subsequent derivatives have been attached to 
oligonucleotides, there is no easy way to reverse the process. A cleavable aniinolink 
to regenerate the oligonucleotide would be extremely useful. 
37 
1.5 Biotin Labelled Oligonucleotides 
Biotin (Figure 1.26), a water soluble vitamin, is a widely used labelling group in 
nucleic acids. It is a convenient, versatile and easily handled molecule and its tight 
binding (Kd = 10 15M) to the egg-white glycoprotein avidin or the non-glycosylated, 
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Figure 1.26 : (+)Biolin 
The methods for biotinylating oligonucleotides are again numerous but to be of 
maximum value they have to be compatible with standard solid phase oligonucleotide 
synthesis. There are two principle strategies: the reaction of an amino functionalised 
oligonucleotide with the biotin as its activated N-hydroxysuccinimidyl ester derivative 
or the direct coupling of a biotin phosphoramidite monomer onto a support bound 
oligonucleotide. 
One of the most common reasons for introducing a terminal amino group into 
an oligonucleotide is for reaction with a biotin derivative (see Section 1.4.4, 
p36).'46'151154 Amino groups can be added to individual nucleotides by means of base 
modifications to permit non-terminal, site specific introduction of one or more biotin 
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Figure 1.28 : Biotin Pizosphoramidite Monomers 
For example, the introduction of a 1,2-bis(2-methylaminoethoxy)ethane to the 4 
position of thymidine and the addition of the p-nitrophenyl biotin active ester (Figure 
1.27). 157  The modification of a sugar ring has also been used to introduce an amino 
group via the periodate oxidation of a 5-terminal uridine residue. 
Biotin phosphoramidites (Figure 1.28) are far more useful since no aniinolink 
synthesis is necessary, no awkward base modification processes are required and 
direct incorporation during oligonucleotide assembly occurs without any post-
synthetic procedures. Furthermore, if the 1' nitrogen of the biotin ring is protected 
with a DMTr group, coupling efficiencies can be measured. Cocuzza158 introduced a 
p-aminophenethyl group to the biotin active ester and then converted this to a 
phosphoramidite [21]. Alves et a 1159 reduced the side chain carboxylic acid on biotin 
to the corresponding alcohol via the methyl ester and then phosphitylated it to give 
[22]. However, the monomers were insoluble in acetonitrile, the universal solvent of 
DNA synthesis and quoted coupling yields were low.159 Wil1160 synthesised two biotin 
monomers containing 3-oxapentyl [23] and octamethylene spaced side arms. These 
were acetonitrile soluble and coupled with extremely high yields. However, the most 
widely used monomer, again acetonitrile soluble and offering high coupling 
efficiencies, was synthesised by Pon '61 by the addition to biotin of t-butyldimethylsilyl 
protected ainnohexanol followed by phosphitylation of the deprotected hydroxyl 
group [24]. 
An important application of biotin is as a label for primers in the polymerase 
chain reaction (PCR), a DNA amplification technique. The PCR products are isolated 
on streptavidin, where binding of the hiotinylated DNA is so strong that recovery of 






2.1 Oligonucleotide Cellular Uptake Enhancement 
The 28mer phosphorothioate, SRev, has been shown to have potent antiviral 
activity against the human immunodeficiency virus (HI 
V).6'  However, this activity is 
limited by the poor cell permeability properties of the oligonucleotide. It has already 
been shown that the attachment of a lipophilic group such as cholesterol improves the 
antiviral activity of SRev. '°6°8 This increased activity is the result of the interaction 
of the lipophilic cholesterol group with the cell membrane leading to cell 
encapsulation (endocytosis) of the oligonucleotide. 
A drawback to the above approach is that once within the cell, the 
oligonucleotide is still linked to the cell membrane via the lipophilic group, cb ing 
it from hybridising with the target mRNA. Therefore, in an attempt to address this 
problem, a monomer containing a disulphide group was synthesised. As it has already 
been shown that a disulphide group is reduced by cellular enzymes but is stable 
outside the cell,' 12  the disulphide containing monomer was introduced between a 
lipophilic group and the oligonucleotide. The disulphide group was to act as a 
cleavable linker, releasing the oligonucleotide from the transport agent once cell 
penetration had occurred. It was hoped that the anti-HIV activity of SRev would be 
significantly increased. 
2.1.1 Synthesis and Coupling of Transport Agents 
Initially it was decided to study those lipophilic groups which had already been 
employed in previous antisense cellular uptake studies. 
Aminohexyl spaced cholesterol [3] (p24, Chol-C6) and 4,4'-dimethoxytrityl 
(DMTr) protected hexadecyl [5] (p26, C16) phosphoramidite monomers were 
synthesised according to the method of MacKellar et al.' 04 To act as a lipophobic 
control, DMTr protected hexaethyleneglycol phosphoramidite monomer [25], (HEG) 
was prepared (Figure 2.1). 162 
43 
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[25] 
Figure 2.1 : Hexaethyleneglycol Monomer 
The I ,2-di-0-hexadecylglyceryl molecule [4] was synthesised according to a 
literature method .1 15-119  However, when the subsequent phosphoramidite monomer 
(C35) was coupled onto the 5'-term1inus of a standard oligonucleotide, problems 
identical to those previously encountered with cholesterol104 were observed. The 
steric bulk of the 1 ,2-di-0-hexadecylglyceryl group inhibited the iodine oxidation step 
of the coupling cycle so that extended treatment was required to achieve quantitative 
reaction. 	More seriously, steric hindrance completely inhibited the action of 
tetraethylthiuram disulphide (TETD) when a sulphurisation step was carried out. 
As a result, an aminohexyl spaced molecule was synthesised (Figure 2.2). 
Compound [4] was reacted with bis(p-nitrophenyl)carbonate [26] in clichioromethane 
in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) to give the carbonate 
[27]. Subsequent reaction with 6-aminohexan1-ol in dichioromethane in the 
presence of triethylamine (TEA) gave the arninohexyl spaced product [28] which was 
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Figure 2.2 : A ininohexyl Spaced 1,2 -di-O-hexadecylglyceryl Monomer 
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Phosphitylation was carried Out in anhydrous dichioromethane in the presence of 
diisopropylethylamine (DIPEA). The phosphitylating reagent, cyanoethyl-N,N-
diisopropylchlorophosphorarnidite, was prepared by the standard procedure. 163  Prior 
to flash chromatography purification of the product [29], the silica-gel was washed 
with anhydrous triethylamine (TEA) to neutralise any acidic groups which might 
protonate the phosphorarnidite monomer and lead to decomposition of the product. 
This procedure was adopted for all flash chromatography purifications involving a 
phosphoran3idite or a functionality protected by the acid labile DMTr group. 
In all cases, purity of the phosphoraniidite monomers was confirmed by 
phosphorus NMR (e.g. compound [29], Figure 2.3). 
147.67 	 3 
Figure 2.3 31P-NMR of [29] 
The synthesis of SRev and other phosphorothioates is an expensive and time 
consuming procedure because of the repeated suiphurisation steps required. Initially, 
therefore, it was decided to attempt automated, solid phase coupling of the monomers 
on the 5-terniini of short oligo dT sequences using standard phosphoramidite 
chemistry. Owing to lack of solubility in acetonitrile, all the hydrophobic monomers 
were dissolved in anhydrous dichloromethane prior to coupling. 	Extra 
-16 
dichioromethane column washes were used in the synthesis cycle to prevent 
precipitation of the monomers and blockage of the reagent lines. In addition, 
extended coupling cycles were used; in particular an extension of the oxidation step to 
avert the problems that might be caused by steric hindrance (see Section 3.2, p  115). 
Table 2.1 
Phosphoramidite 3 5 25 29 
Coupling Efficiency (%) 93 94 79 85 
Terminal dT Coupling (%) N/A 93 89 N/A 
The coupling efficiencies obtained (Table 2.1) were all confirmed by reverse phase 
HPLC analysis (e.g. compound [29], Figure 2.4, using Gradient 1, p120) with the 
product (peak B) eluting considerably later than the failure sequences (A). Where the 
monomer was hexadecyl [5] or hexaethyleneglycol [25], detritylation led to the 
exposure of a further 5'-hydroxyl functionality. To confirm the success of the 
monomer couplings, a standard 2'-deoxythymidine phosphoramidite monomer was 
coupled onto the 5'-ternini of oligonucleotides bearing detritylated MEG or C16 
groups. The coupling efficiencies thus obtained by coupling onto these groups are 
indicated in Table 2.1 (for the methods used to calculate the coupling efficiencies, see 









A: Failure Sequences B : C35-C6-dT5 




A : Failure Sequences B : C35-C6-SRev 
Figure 2.5: G35-C6 + SRev 
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The coupling efficiencies were considered sufficiently high for all the monomers 
to be subsequently used in the synthesis of SRev and analogues of SRev. The same 
oxidation cycle could be used for the coupling of the lipophilic monomers onto the 
phosphorothioate 28mers but the resulting phosphodiester linkages would be 
vulnerable to hydrolysis by DNase enzymes. Sulphurisation with TETD to give the 
enzymatically stable phosphorothioates was therefore carried Out. This proceeded 
satisfactorily for the aminohexyl spaced 1,2-di-0-hexadecylglyceroxy monomer [29], 
as confirmed by HPLC analysis (e.g. [29], Figure 2.5, Gradient 1). 
As an antisense control, the phosphoramidite monomers [3],  [5] and [29] were 
coupled to the 5-terminus of two other 28mer phosphorothioates. The two 
sequences were SRandom, d(CTG GTC TCG TTC GCC TCT CTT CTC CCG A), 
containing the same base composition as Srev but with a scrambled sequence and an 
oligo dC 28mer phosphorothioate (SdC28). Both of which would be unable to 
hybridise to the target rnRNA on the rev gene. Again, in each case the final 
suiphurisation step proceeded as standard with HPLC traces showing the yields of the 
desired oligonucleotides to be equivalent to the SRev examples. 
49 
2.1.2 Synthesis of Disulphide Phosphoramidites 
In the majority of literature examples, the disulphide group is introduced into an 
oligonucleotide by the reaction of an amino functionalised oligonucleotide,129 '32 by 
chemistry involving a disulphide exchange reaction' 3 '24 '25"3° or by solid support 
modification. 124-127 Relatively straightforward means exist to obtain a 3-disulphide' 26 
but only H-phosphonate chemistry has ever been employed to introduce a disulphide 
monomer at the 5-terminus.' 2 
I) Na 2S203 












DMTrO S_S O_P\ CN 
[32] 
Figure 2.6 : Disulphide Phosp/wramidite Monomer 
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A simple, disulphide containing phosphoramidite monomer would offer a superior 
methodology for 5'-disulphide incorporation into oligonucleotides. 
A propyl linked disulphide unit [3011 (Figure 2.6) was prepared from 3-
bromopropan-i-ol using Bunte salt chemistry."'" Sodium thiosuiphate was used to 
convert the brorno alcohol to the thiol alcohol which was then oxidised to the 
disulphide by iodine in an ethanol/water solvent. Without further purification, this 
was reacted with an equivalent of 4,4-dimethoxytrityl chloride in pyridine. Careful 
purification led to the product alcohol [31] which was then phosphitylated to the 
phosphoramidite monomer [32]. As is standard for phosphoramidites, purification of 
the monomer [32] was carried out rapidly to avoid oxidation. Fortunately, compound 
[32] possessed good solubility in acetonitrile and so standard coupling cycles could be 
used. 
However, despite being a single spot on thin layer chromatography (tic), the 
phosphorus-NMR spectrum of the purified monomer [32] indicated the presence of a 
large number of impurities. Solid phase coupling of the monomer as a 0.1M solution 
in acetonitrile onto the 5-tenninus of a dT sequence 5 nucleotides in length was low 
(52%) and the problem was assumed to be the result of disulphide cleavage by 
phosphorus (III) compounds present (Figure 2.7). 
DMTrO 	 S S 	0— 
Figure 2.7 
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Throughout the phosphitylation procedure to prepare monomer [32], the 
disulphide unit was exposed to disulphide cleavage conditions. 	Both the 
phosphitylating reagent and the monomer itself contain a phosphorus atom hi its 
trivalent state capable of reducing the disulphide bond. 
In an attempt to limit the exposure of the disulphide unit to the phosphitylating 
reagent, reaction times for the phosphitylation step were substantially reduced from 
the standard 1 hour down to 20 minutes. Again, on tic, the product appeared as a 
single compound but on this occasion, the coupling efficiency was much improved 
(82%). As before, however, there was evidence for P(III) catalysed disulphide 
reduction. After being left for 30 minutes on the DNA synthesiser in solution, the 
disulphide monomer was coupled again onto an identical oligo dT sequence to give a 
coupling efficiency of 51%. Clearly, as compound [32] is a phosphoramidite 
monomer, it contains a P(III) atom and this atom is capable of reducing the disulphide 
unit. Whenever an attempt is made to use the monomer, this self-cleaving process is 
unavoidable and poses a considerable problem. 
Nevertheless, further attempts were made to synthesise a purer sample of [32]. 
31P-NMR spectra always showed the presence of a characteristic phosphoramidite 
peak (6 147-150), but also present were numerous other unidentified signals which 
did not correlate to any obvious side-product. However, coupling efficiencies were 
low and remained low (30-50%) despite attempted modifications to the monomer 
synthesis or the DNA synthesis cycle: for example, reducing the phosphitylating 
reaction times still further, extending the automated coupling cycle for the monomer 
and even changing to the less reactive phosphitylating reagent, 2-cyanoethyl-
N,N,N',N-tetrai sopropyiphosphoramidite. 
A further problem with the disulphide monomer [32] is that once it has been 
coupled to the support bound oligonucleotide it is necessary to couple onto it a 
lipophilic phosphoramidite monomer, thereby exposing the disulphide unit to further 
P(III) containing compounds. It was expected that any further coupling would also 
52 
be of substantially reduced efficiency and although significantly less pronounced than 
predicted, this was later shown to be the case. 
As a means of circumventing this problem, it was decided to combine the 
disulphide and lipophilic groups in the same monomer. Hence only one coupling 
reaction would be required instead of two. Initially, the cholesteryl and 1,2-di-0-
hexadecylglyceroxy groups were selected to test this idea. A similar strategy was 
adopted to the syntheses of the aminohexyl linked monomers [3] (p24) and [29] 
(p45). 
The partially protected disulphide unit [31] was converted into its analogous 
amine [351 using the Gabriel synthesis and following a procedure based on that of 
Will (Figure 2.8).b60  The terminal hydroxyl group was reacted with tosyl chloride in 
pyridine to give the tosyl derivative [33]. The tosyl group was then displaced by 
potassium phihalimide in N,N-dimethylformamide (DMF) to give the phthalimide 
[34]. 	Reduction with hydrazine hydrate was carried out in a (1:1) 
dichloromethane/methanol mixture (owing to the lack of solubility of [34] in methanol 
alone). 
The resulting amine [35] was then reacted with 1,2-di-0-hexadecylglyceroxy(p-
nitrophenylcarbonate) [27] (Figure 2.9) and cholesteryl chioroformate [1] (Figure 
2.10) respectively to give the products [36] and [38]. Detritylation was carried out 
with 5% trichloroacetic acid (TCA) in dichloromethane. The cholesteryl derivative 
[38] deprotected smoothly to give the product [39]. The 1,2-di-0-hexadecylglyceryl 
derivative [36],  however, gave two products under deprotection conditions. One of 
these was shown to be the thiol resulting from cleavage of the disulphide bond, 
although the reasons for this side reaction remain unclear. Interestingly, absolutely no 
analogous product was observed when the cholesteryl derivative was treated with 
TCA. The yield of the desired product [37] was extremely low(39%. 
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Figure 2.9 : 1,2-Di-0-/,.exadecylglyceryl Disulphide 
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Figure 2.10 Cholesteryl Disulphide 
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Further problems were encountered when the two compounds [37] and [39] 
were subjected to phosphitylation. In both cases, during the standard phosphitylation 
procedure, multiple products appeared on tic. Even though the phosphoraniidite 
targets appeared to be the predominant products, following purification, the 31P-
NMR spectra of both samples were complex, containing numerous signals, none of 
which could be assigned, but more significantly, there were no peaks at all in the 
phosphoramidite region. Attempted automated solid phase couplings onto dT 5mers 
in anhydrous dichioromethane indicated negligable coupling and no products were 
observed during subsequent HPLC analyses. Reduced reaction times during 
phosphitylation gave the same results. 
Again, the reasons for these observations were unclear. Instead of stericaily 
protecting the disulphide group during phosphitylation, the bulky choiesteryi and 1,2-
di-0-hexadecyiglyceryl groups appeared to destabilise the molecules. Clearly, they 
could not be used to synthesise the desired oligonucleotides. 
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2.1.3 The Phosphotriester Approach 
2.1.3.1 Synthesis of Disulphide Phosphotriesters 
It seems most likely that the lack of stability of a disulphide group in a 
phosphoramidite molecule is caused by disulphide reduction by P(III) species. During 
peptide synthesis, the thiol group of cysteine residues is often protected by converting 
it into a disulphide; 166  deprotection is achieved by reduction, usually with standard 
reducing agents such as sodium borohydride, but it can be achieved by using uialkyl 
phosphines e g. n-tributylphosphine (TBP). 	It is therefore likely that any 
oligonucleotide synthesis approach involving disulphide groups should avoid the 
inclusion of any phosphorus atoms in the trivalent oxidation state. For that reason, it 
was decided to use phosphotriester chemistry. In this approach, all phosphorus atoms 
exist in their P(V) state throughout oligonucleotide assembly. 
The same basic approach i.e. the synthesis of a simple monomer containing a 
disulphide group, was adopted as before. As in the phosphoramidite approach, 
phosphotriester chain extension is the 3' to 5' direction; therefore the coupling of such 
a monomer would again automatically be onto the 5-terminus of an oligonucleotide. 
The basic disulphide unit [31] was subjected to a standard phosphotriester 
phosphorylation (Figure 2.11), a one-pot procedure in tetrahydrofuran (THF) in the 
presence oY base (TEA). Once the product [40] had formed from the reaction 
between the disulphide compound [31] and the phosphorylating reagent, 2-
chlorophenyldichlorophosphate, the reaction mixture was quenched with aqueous 
1.OM triethylammoniurn bicarbonate (TEAB). With the phosphorylating reagent 
containing two chlorine atoms, both capable of acting as leaving groups, there was 
evidence (on tic) for the disulphide unit [31] substituting at both positions. Exposure 
to aqueous TEAB ensured that this disubstitution occurred to only a minor extent. 
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Figure 2.11 Disulphide Phosphotriester Monomer 
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The phosphotriester monomer [41] thus synthesised was purified by silica-gel flash 
chromatography, on this occasion with the added precaution of having TEA present in 
the eluent throughout to ensure that the monomer remained as a triethylarnmonium 
salt. Attempts to convert the yellow oil to a solid foam were unsuccessful. 
Nevertheless, the characteristic phosphotriester peak (ö -4.49) observed on the 31P-
NMR (Figure 2.12) indicated that the monomer was of high purity. 
-4.49 
Figure 2.12 : 31P-NMR of [4 1] 
Modifying an automated DNA synthesiser to be compatible with 
phosphotriester chemistry is clearly perfectly feasible but it was decided to retain 
phosphoramidite chemistry for coupling of standard monomers. All phosphotriester 
monomers were added in a non-automated procedure. Coupling efficiencies of the 
ti-lester monomer, outlined below (Table 2.2), were all obtained by returning the 
synthesis column to the DNA synthesiser once the phosphotriester monomer had been 
coupled and cleaving the terminal 4.4'-dimethoxytrityl group. 
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Trdi7o 
Monomer (mg) 54 54 81 108 108 108 108 
MSNT(eg.) 2 2 2 2 3 1 3 
pyridine (%) So 10 10 10 10 10 10 
MeCN (%) 50 90 90 90 1 	90 90 90 
Coupling Time (mins.) 90 90 90 90 90 90 45 
Coupling Efficiency (%) 69 75 88 92 95 31 68 
Pyridine - doubly distilled prior to use - is the standard solvent in 
phosphotriester couplings but it tends to cause clumping of the CPG resin and 
blocking of the reactive sites. To avoid this, anhydrous acetonitrile (50%) was 
employed in the solvent mixture for the phosphotriester coupling procedure. The 
concentration of the monomer [41] was initially based on standard phosphotriester 
couplings (-0.1M)167 and 2 equivalents of the condensing agent 1-(2-
mesitylenesulphonyl)-1,2,4-triazole (MSNT) were used. A sufficient volume of 
solvent was taken (0.20m1) to fill the synthesis column and to ensure that all the air 
bubbles could be ejected. To ensure complete reaction, coupling times of 90 minutes 
were used. 
With a coupling efficiency of 69%, the very first attempt to couple the monomer 
onto a dT Smer sequence was extremely promising. However, extensive clumping of 
the solid support beads was observed. Continual agitation of the synthesis column 
was required to promote the reaction. The anhydrous acetonitrile content of the 
solvent mixture was increased still further (90%) and coupling of the monomer [41] 
was repeated. On this occasion, movement of the CPG resin within the synthesis 
column was unrestricted due to the increased MeCN content and only occasional 
agitation was required to obtain a coupling efficiency of 75%. 
Increases in the concentration of the monomer solution, by 50% then by 100% 
over the original values, resulted in significant increases in the coupling efficiencies 
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recorded (88%, 92%). Fixing the monomer concentrations at 108mg (0.14mmol) per 
addition, the MSNT content was increased to 3 equivalents (0.42mmol). The 
resulting coupling efficiency (95%) was consistent to within 2% over two couplings 
attempted subsequently under identical conditions and was very close to the optimum 
possible for phosphotriester chemistry. It was certainly sufficient for the intended 
application and considerably superior to the phosphoramidite disulphide monomer. In 
addition, the phosphotriester disulphide monomer was stable over a considerable 
period of time, with no significant reduction in coupling efficiency observed after 
storage for 6 months at -60C. 
That such a large quantity of MSNT (123mg) was required for each 
phosphotriester addition was confirmed by the considerable reduction in coupling 
efficiency observed (3 1%) when only one equivalent was used. This perhaps implies 
that moisture was present in the solvents or the monomer and that the MSNT was 
acting as a drying agent. However, the pyridine was doubly distilled and the triester 
monomer was dried overnight in a vacuum desiccator immediately prior to use to give 
conditions as close to anhydrous as possible. 
The only drawback to the coupling procedure adopted was the 90 minute 
coupling time, significantly longer than a standard phosphotriester coupling cycle (40 
minutes without N-methylimidazole).33 The lower coupling efficiency obtained (68%) 
when the coupling time was reduced by 50% suggested that 90 minutes were indeed 
justified to ensure optimum coupling yields. To enable this time to be reduced, one 
equivalent of the catalyst, N-methylimidazole (0.14mmol, 1 1tl), was added to the 
solvent mixture prior to the coupling reaction. After a 30 minute reaction, subsequent 
analysis indicated a complete absence of any product. The N-methylimidazole was 
carefully distilled to remove any moisture which might have been interfering with the 
reaction. but the result was the same. Even a 90 minute coupling reaction with N-
methylimidazole present yielded no product whatsoever. The N-methylimidazole 
appeared to inhibit the phosphotriester addition process for this monomer. 
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2.1.3.2 Cleavage of the Aryl Protecting Group 
The o-chlorophenyl phosphate protecting group is usually removed by oximate 
anion 29 but cleavage can be carried out simply by heating with ammonium 
hydroxide. 30  In addition to being a simpler procedure, ammonium hydroxide 
treatment is compatible with the standard base deprotection protocol - heating at 
55 0C for 5 hours - which follows oligonucleotide cleavage from the solid support, 
therefore reducing the number of deprotection steps by one. It has been reported that 
ammonium hydroxide treatment causes some cleavage (2-3%) of the oligonucleotide 
backbone at every aryl protected phosphate.3° However, when there is only one o-
chlorophenyl group present in the oligonucleotide chain, as is the case here, this effect 
should be minimal. 
To test rhis, an oligo dT sequence 15 nucleotides in length was synthesised and 
the disulphide 1.Thosphotriester monomer [41] (SS) was coupled to its 5'-terminus. On 
reverse phase HPLC, oligonucleotides elute according to their levels of 
hydrophobicity; if an oligonucleotide still carries a DMTr group, during HPLC 
analysis it elutes considerable later than its failure sequences enabling it to be more 
clearly visualised and more easily purified. Therefore, on this occasion, the DMTr 
protecting group was left on the oligonucleotide after synthesis. 
Following automated cleavage from the solid support, the oligonucleotide was 
heated at 550C in ammonium hydroxide and analysed on HPLC at one hourly 
intervals (Figures 2.13-2.17, Gradient 2). As a consequence of using an oligo dT 
sequence, no base protecting groups were present and simplified HPLC traces were 
obtained. As can be clearly seen, the peak for the fully protected oligonucleotide (A) 
diminished as the product of o-chlorophenyl cleavage (B) increased with the failure 
sequences (C) showing little change. The reaction was almost complete after 3 hours 
and after 5 hours, negligible amounts of the o-chlorophenyl protected oligonucleotide 
remained. It was also clear that negligible cleavage of the oligonucleotide backbone 
by base occurred, as virtually no product loss was observed upon prolonged heating 
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in aqueous ammonia. This stability was confirmed by showing that the HPLC trace of 
overnight heating in ammonium hydroxide was identical to that after heating for 5 
hours. 
Another sample of [41] coupled to a dT15 oligonucleotide was treated with 2-
nitrobenzaldoxime in a dioxane/water mixture in the presence of base (1,1,3,3- 
tetramethylguanidine) at 37°C overnight'67 with the same result. Thus heating in 
ammonium hydroxide offered a simple, convenient means to cleave the aryl protecting 
group from the phosphotriester. 
A 
% MeCN 
5.00 	10.00 	15.0n 	20.00 	25.00 
Time (mins.) 
A : SS-dT15 + o-chlorophenyl B : SS-dT15 C : Failure Sequences 





A : SS-dTl5 + 0-chlorophenyl B : SS-dT15 C: Failure Sequences 
Figure 2.14: SS + dT15 (1 hr., 550C) 
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5.00 	10,00 	 5,00 	20.00 	25.00 
Time (mins.) 
A: SS-dT15 + o-chlorophcnyl B : SS-dT15 C: Failure Sequences 




5.00 	10.00 	15.00 	20.00 	25.00 
Tirnc (mins.) 
A : SS-dT15 + o-chloropheny! B : SS-dTl5 C: Failure Sequences 






5.00 	10.00 	 5.00 	20.00 	25.00 
Tune (mins.) 
A : SS-dT15 + 0-chiorophenyl B : SS-dT15 C : Failure Sequences 
Figure 2.17 : SS + dTI5 (5/irs., 550C) 
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2.1.3.3 Cleavage of the Disulphide Bond 
The standard method for disulphide bond cleavage involves treatment with 
dithiothreitol (DTT) 121  in the presence of base. The dT 15mer sequence with the 
disulphide phosphotriester monomer coupled to the 5'-terminus was made as before 
and the o-chlorophenyl group was removed with ammonium hydroxide. The product 
oligonucleotide was purified by reverse phase HPLC (Figure 2.18, peak A, Gradient 
2, p120) then treated with an excess of DTT (50mg, 0.32mmol) in aqueous buffer in 
the presence of ammonium hydroxide. After one hour, the sample was run down a 
Sephadex G25 gel filtration column. These nucleic acid purification (NAP) columns 
are used for oligonucleotides greater than 12 residues in length, retaining all small 
molecules and shorter oligonucleotides. In this way, excess DTT and the small DMTr 
protected propylthiol fragment produced by the cleavage reaction were removed. The 
resultant oligonucleotide, bearing a 5-propyithiol group, was analysed on HPLC 
(Figure 2.19). The loss of the DMTr group from the 5-terminus as a result of 
disulphide cleavage gave the product a far earlier elution time (B) than the starting 
material (A). Significantly, disulphide cleavage occurred practically quantitatively; 
virtually no trace of the starting material could be seen on the HPLC trace. When the 
product of cleavage was treated with dithio-bis-2-nitrobenzoic acid E11man's 
reagent), a bright yellow colour resulted, confirming the presence of a thiol group. 
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5.00 	10.00 	15.00 	20.00 	25.00 
Time (mills.) 
HS-clT15 
Figure 2.19 : (SS-dT15) + DTT 
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To further prove that disulphide bond cleavage was indeed occurring and simple 
detritylation was not responsible for the above observations, a disulphide group was 
incorporated within an oligonucleotide sequence. Again, an oligo dT sequence was 
synthesised, 10 nucleotides in length, and the phosphotriester monomer [41] was 
coupled onto the 5-terminus using the standard procedure. On this occasion, 
however, upon returning the solid support to the DNA synthesiser, automated 
capping and detritylation were performed and a further six 2-deoxythymidine residues 
were coupled on to give the sequence dT6-SS-dTl0. Subsequent HPLC analysis of 
the deprotected product (peak A, Figure 2.20, Gradient 3, p120) indicated a high 
yield and when the product was subjected to DTT treatment, two clear products in 
virtually identical yield were observed (peaks B and C, Figure 2.21). To enable both 
cleaved oligonucleotide strands to be detectable on HPLC, no gel filtration process 
was employed following DTT treatment since oligonucleotides shorter than 12 
nucleotides in length are removed by gel filtration. For that reason, impurities arising 
from the presence of DTT were observed on the HPLC trace (peaks D and E). A 
mixed sample of the starting material and purified products was also analysed on 
HPLC and, although the concentrations of the samples differ, the 3 peaks (A, B and 
C) could quite clearly be seen (Figure 2.22); the oligonucleotide bearing a disulphide 
group and sixteen 2-deoxythymidine residues eluted last (peak A), preceded by a dT 
lOmer bearing a 5-propylthiol group (peak C) and a dT 6mer bearing a 3'-propylthiol 
group (peak B). Both of the cleaved fragments reacted with Eliman's reagent and the 
starting material gave no reaction. Furthermore, a dT16 sequence containing no 
disulphide units was synthesised; it showed no change following DTT treatment and 
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Figure 2.21 dT6-SS-dTlO + DTT 
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2.1.3.4 Oligonucleotides Containing 3'-Disulphides 
Each of the six 2-deoxythyrnidine residues coupled onto the disulphide unit 
during the course of the dT6-[41]-dTlO oligonucleotide synthesis above was 
monitored for coupling efficiency by trityl analysis. Each nucleotide was added as a 
phosphoramidite monomer and it was therefore expected that coupling efficiencies 
would be low. Interestingly, however, only the first nucleotide addition was poor 
(79% coupling efficiency) and every subsequent addition was of standard efficiency 
(98% average). A similar result was obtained - 83% for the first addition, an average 
of 97% for the rest - when the experiment was repeated. The addition of a standard 
phosphotriester monomer, in this case a 2-deoxycytidine monomer, onto the 
disulphide under the same conditions used for the disulphide phosphotriester 
monomer, gave a coupling efficiency of 97% with all subsequent phosphoramidite 
additions again as standard (97% average). 
A possible explanation for these observations is that after the first addition onto 
the disulphide, the disulphide group is subsequently sterically protected by the 
growing oligonucleotide chain from further P(III) attack. A more likely answer, 
however, is to do with the automated phosphoramidite coupling cycle. Every 
phosphoramidite monomer is treated with the activating agent, tetrazole, prior to 
exposure to the solid support bound oligonucleotide. In this way, due to protonation 
of the nitrogen atom of the diisopropyl group of the phosphoramidite moiety, the lone 
pair on the phosphorus atom is unavailable to participate in the disulphide bond 
reduction shown in Figure 2.7 (p51). Possibly, a small proportion of the P(III) atoms 
of the phosphoramidite monomer are unprotonated by the tetrazole and therefore, at 
the time of exposure to the disulphide bond, the unprotonated monomer can still 
cause significant disulphide reduction. However, for all subsequent additions the 
disulphide bond is sufficiently sterically protected to inhibit this process. It is also 
possible that being primarily a polyalkyl chain, the disulphide unit, when at the 5'-
terminus of an oligonucleotide, can adopt a variety of conformations, perhaps forming 
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a hydrophobic pocket, hindering initial attack by P(III) but henceforth fixed into a 
rigid conformation. The results obtained when coupling onto the hexadecyl [5] and 
hexaethyleneglycol [25] groups with a 2'-deoxythymidine residue (see p47) seem to 
support this theory. 
On a number of occasion s,124127  a 3'-disulphide group has been introduced into 
an oligonucleotide by solid support modifications. In each case, no substandard 
coupling efficiencies were reported. It was decided to repeat this work by using the 
disulphide Lrnit [31] (p50). 
A standard controlled pore glass (CPG) derivatisation procedure was adopted. 
Aminopropyl functionalised CPG was washed with TCA then succinylated with 
succinic anhydride. 	The resultant carboxylic acid was activated with 4- 
dimethylaminopyridine (D MAP) and 1 -(3-dirnethylaminopropyl)-3-ethyl-carbodiimide 
(DEC) hydrochloride and esterified by addition of the disulphide containing alcohol 
[31]. The unreacted succinate groups were then removed by treatment with 
piperidine and the unreacted amino groups were capped with acetic anhydride. A 
loading of 58tmol 1 of [31] on the CPG was obtained. 
Approximately 8mg of the disulphide derivatised CPG resin were loaded onto a 
DNA synthesis column and a dT12 sequence was synthesised using standard 
phosphoramidite chemistry. Every single coupling efficiency was 98%±1%. 
The product was analysed on HPLC (peak A, Figure 2.23, Gradient 3) then 
treated with DTT and gel filtered as before (peak B, Figure 2.24). The difference in 
lipophilicity caused by having a disulphide group or a thiol at the 3-terminus of an 
oligonucleotide is very small. However, the two oligonucleotides appeared to have 
slightly different elution times on HPLC under the same conditions (A, —15.5mins. 
and B, —14.5mins.) and although the analysis of a mixed sample shows only one main 
peak (A + B. Figure 2.25), there was a definite shoulder on that peak, suggesting the 









Time (mins) 	 - 
B clTl2-SH 
Figure 2.24 (dT12-SS) + DTT 




A + B : dT12-SS + dT12-SH 
Figure 2.25: dTl2-SS + dT12-SH 
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In addition, the product of the cleavage reaction reacted with Eliman's reagent 
whereas the starting oligonucleotide did not. 
It can therefore be concluded that phosphoramidite couplings onto an 
oligonucleotide bearing a 3'-alkyl disulphide group pose no significant problems. 
Where the disulphide group is bound directly to the solid support and is therefore 
more hindered, even the first phosphoramidite addition onto the disulphide group 
proceeds well. 
2.1.3.5 Cleavable Cholesterol Groups 
Having established a consistent, high yielding method for the addition of a 
disulphide unit onto an oligonucleotide, a means was sought for the introduction of a 
lipophilic group. It had already been shown that the coupling of a phosphotriester 
monomer onto a 5-terminal disulphide (dC, 97%) gives a superior yield to a 
phosphoramidite monomer coupling (dT, 79-83%). Thus it was decided to start by 
synthesising a cholesterol phosphotriester monomer. 
The phosphorylation procedure (Figure 2.26) on this occasion required an 
overnight reaction due to stei-IC inhibition of the reaction by the cholesterol moiety. 
However, for the same reason, no disubstitution by the cholesterol group on the 
phosphorylating reagent had occurred. The product [42] (Chol) was isolated as a 
white solid in a moderate yield (68%). The only change to the coupling procedure 
was the replacement of anhydrous acetonitrile by anhydrous TI-iF in the solvent 
mixture to aid solubility. The same quantitiy of monomer (0.14mmol, 94mg) and 
MSNT (3 equivalents) were used as for the disulphide phosphotriester couplings. 
Initially coupling was attempted onto the 5-hydroxyl group of an oligo dT sequence 













Figure 2.26: Cholesterol Phosphotriester Monomer 
Unfortunately, a coupling efficiency of only 31% was obtained. When gentle 
heating was applied to the synthesis column during the reaction (500C for 30 minutes) 
the coupling efficiency was only marginally improved (46%). The problem was 
assumed to be the result of steric hindrance by the bulky cholesterol group. Even 
when the cholesterol phosphotriester monomer was coupled onto an oligonucleotide 
bearing a 5-terminal hydroxy dipropyldisuiphide group, less hindered than a terminal 
2'-deoxythymidine residue, there was no real improvement in coupling efficiency 
(51%). Attempts to increase the duration of the coupling reaction or increasing the 














Figure 2.27: Aminohexyl-Cholesteiyl Phosphotriester Monomer 
Next, the aminohexyl spaced cholesterol molecule [21 
104  was phosphorylated 
(Figure 2.27). Only a slightly extended phosphorylation reaction time was required 
(5hrs.) and some disubstitution was observed on tic. However, problems were 
encountered during purification of the resulting monomer [43]. The compound 
appeared to be unstable during flash chromatography, reacting to give a side-product. 
Attempts to identify this were unsuccessful: the single signal observed on 31P-NMR 
(S -10) was outside the normal range for phosphotriester compounds (5 -4.0 to -6.0); 
the 'H-N MR was dominated by the cholesterol moiety signals; and the mass spectrum 
contained signals which did not correlate to any obvious side-product. Only a 
moderate yield (57%) of the correct material, again a white solid, was recovered. It 
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was coupled onto the 5-hydroxyl group of a dT 15mer sequence in anhydrous 
TI-IF/doubly distilled pyridine (9:1) in the standard concentration (0.14mmol, 115mg). 
However, the measured coupling efficiency was poor (32%). Another attempt 
involving mild heating (500C for half an hour) resulted in no real improvement (36% 
coupling efficiency). The side product did not couple whatsoever when treated under 
the same conditions. Attempts to repeat the phosphorylation reaction resulted in even 
poorer yields and lower purity. 	When attempts were made to purify the 
phosphotriester monomer [43] using an alumina or cellulose column the same result 
was obtained. The coupling efficiency of the unpurified monomer [43] was low 
(25%) as would be expected. 
A curious solvent effect was observed during these studies; when the anhydrous 
TI-IF content of the solvent mixture during the phosphotriester coupling procedure 
was replaced with anhydrous dichioromethane in which the cholesterol monomers 
[42] and [43] also dissolved, the coupling reaction was completely inhibited. This 
occurrence was independent of the monomers as shown by carrying out the coupling 
procedure in the absence of any monomer but with the other conditions as normal 
(123mg MSNT. 10% pyridine). When anhydrous TI-IF was the solvent, no blocking of 
the available 5-hydroxyl groups on the test oligonucleotide was observed (when the 
synthesis column was returned to the DNA synthesiser, a coupling efficiency of 98% 
was obtained for the addition of a standard dT residue). With the use of anhydrous 
dichioromethane as the solvent in the identical reaction, the opposite result occurred 
and no further addition onto the oligonucleotide was possible. 
As a comparison to the phosphotriester cholesterol monomers, the 
phosphoramidite aminohexyl spaced cholesterol monomer [3] (p24, Chol-C6) was 
synthesised and coupled onto two dT Smer oligonucleotides, one with and one 
without a 5-terminal disulphide unit attached. The same extended phosphoramidite 
coupling cycle with anhydrous dichloromethane as solvent was used as before. Again, 
coupling onto the unmodified oligonucleotide was at a 93% coupling efficiency. 
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However, although slightly reduced from this, the coupling efficiency onto the 5'-
disulphide group (83%) was still considerably higher than any coupling efficiency 
obtained using the cholesterol phosphotriester monomers above. 
These values were confirmed by HPLC analysis. The chromatogram for the 
best of the phosphotriester cholesterol couplings onto a dT 5mer bearing the 
disulphide unit (Figure 2.28, Gradient 1, p120) clearly showed a far higher failure 
sequence content (peak A) and far less product (peak B) then the trace for the 
phosphoramidite cholesterol monomer [3] coupled onto a dT 5mer bearing the 
terminal dipropyldisuiphide group (Figure 2.29). 
To prove its identity, the product from Figure 2.29 (peak B) was collected and 
treated with DTT in the standard procedure. Gel filtration was not carried Out as this 
would cause the loss of the oligonucleotide (only five residues in length). HPLC 
analysis was carried out on the product (Figure 2.30), revealing virtually quantitative 
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C + D: Excess DTT + Cleavage Products 
Figure 2.30: (CIwl-C6-SS-M) + DTT 
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With a viable route to disulphide linked cholesterol oligonucleotides now 
established, it was decided not to pursue other synthetic methods. Interest in 
synthesising the molecules [37] (p55) and [39] (P56) with the lipophilic group and 
disulphide unit in the same molecule and converting them into phosphotriester 
monomers was set aside. 
The phosphorothioate oligonucleotide, SRev, was synthesised once again and 
the phosphotriester disulphide monomer [41] (p59) was coupled onto its 5'-terminus 
using the standard non-automated procedure. Upon returning the synthesis column to 
the DNA synthesiser, capping and detritylation steps were carried out and the 
aminohexyl spaced cholesterol monomer [3] was added. The HPLC trace for the 
purified product is shown (Figure 2.31, Gradient 1). The use of TETD for the 
sulphurisation step following the addition of monomer [3] could have resulted in some 
cleavage of the disulphide bond, causing the slightly reduced yield observed on HPLC 
analysis. The double peaks observed on both the failure sequences (peak A) and the 
product oligonucleotide (peak B) are a common feature of phosphorothioates bearing 
5'-hydrophobic groups due to the interaction of the hydrophobic groups with the RJS 
isomer mix at phosphorothioate phosphorus atoms. 	Again, DTT treatment 
successfully cleaved the disulphide bond (Figure 2.32), with the single peak (C) 
obtained aftei gel filtration. The cleaved product (peak C) reacted with Ellman's 
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Figure 2.32 : (CJzoI-C6-SS-SRei') ± DTT 
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Thus the potential anti-viral oligonucleotide, SRev, was synthesised bearing a 
cleavable cholesterol group. The synthesis procedure involved both phosphoramidite 
and phosphotriester chemistry with every coupling of high yield. This offers an 
alternative approach to the only other existing method for the synthesis of this type of 
modified oligonucleotide. Although not quoted, the yields from the published 
approach' 12  are likely to be lower as H-phosphonate chemistry was used throughout 
and generally H-phosphonate coupling efficiencies are only —95%, much worse than 
those obtained from either phosphoramidite (98-99%) or phosphotriester (-97%) 
chemistry. 
If cellular uptake tests on the cleavable, cholesterol linked SRev oligonucleotide 
show promise, other lipophilic groups such as hexadecyl or 1,2-di-O-
hexadecylglyceryl [4] (p45) can be added via a cleavable disulphide linker to SRev or 
any other oligonucleotide in an analogous manner. 
2.1.3.6 Phosphorothioate Disulphide Monomers 
A weakness in the cleavable cholesterol SRev oligonucleotide synthesised above 
is the single phosphodiester linkage between the disulphide group and the 
oligonucleotide. As cellular degradation of oligonucleotides occurs principally by the 
action of 3-exonucleases and the unnatural 5-monomer is unlikely to be a substrate 
for DNase nucleases, the significance of this weakness may be minimal. However, a 
means was sought to introduce a phosphorothioate linkage at this site. 
The basic phosphorothioate building block, 2,5-dichlorophenyl-O,O-bis[(6-
trifluoromethyl)- 1 -henzorriazoyl j phosphoroth bate [44] was synthesised by the 
standard method and dissolved to give a 0.2M solution in dioxane.7475 This was 
reacted with the alcohol function of the disulphide unit [31] (Figure 2.33). 
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Figure 2.33 : Phosphorothioate Disulphide Monomer 
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In the method of de Vroom et ai,Th  the whole coupling procedure was carried 
out in a one-pot, solution phase reaction. However, it was decided to isolate the 
product of the above reaction, [45], in order to enable solid phase addition of the 
monomer [45] according to the protocol adopted above. Two clear peaks were 
obtained on the 31P-NMR spectrum of [45] (Figure 2.34), consistent with the 
expected R/S mixed stereochemistry at the phosphorus atom. The exact ratio 
between the peaks varied considerably between individual syntheses but the signal of 
higher 8 value (55.03) was always of greater intensity, a phenomenon observed by 
others .72 
Figure 2.34 31P-NMR of 1451 
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A short dT 5mer sequence was synthesised and coupling was attempted with 
the monomer [45]. The same conditions used for the disulphide monomer [41] were 
initially adopted - 0.1 4mmol (128mg) of monomer, anhydrous acetonitrile/doubly 
distilled pyridine (9:1, 0.20m1), 90 minutes coupling time - except for the absence of 
MSNT. Success was limited (20% coupling efficiency from nityl analysis) and 
subsequent increases in monomer concentration and coupling time resulted in little 
change (Table 2.3). The addition of N-methylimidazole into the solution mixture 
again resulted in complete inhibition of the reaction. 
Tnh1' 7 
Monomer (mmol) 0.14 0.30 0.42 
Coupling Time (hrs.) 1.5 2.5 16 
Coupling Efficiency (%) 20 20 26 
The monomer [45] did not couple well under any of the conditions attempted. 
As a result, the cleavable, cholesterol linked SRev oligonucleotide was not 
synthesised as a full phosphorothioate. All previous attempts at synthesising 
phosphotriester phosphorothioates have been in solution phase only7275 with dimers 
formed in one-pot procedures. Perhaps this approach was not compatible with solid 
phase addition involving separate isolation of the monomers. However, no further 
investigations were carried out into the possibility of adapting the above work to 
solution phase synthesis. 
(For a complete list of the oli(lonucleotides synthesised for anti-HIV testing, see 
Appendix). 
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2.2 Oligonucleotides Containing 5'-Thiols 
Thiol groups at the 5-terminus of oligonucleotides offer a simple and effective 
means for the attachment of thiol specific probes and reporter groups such as 
fluorescent dyes. 124-126,134  In addition, they can be used for the coupling of peptides 
and proteins to oligonucleotides under mild chemical conditions. '24125 Literature 
routes to 5-terminal thiols involve the addition of trityl protected monomers, 
134,135,137 
or a reaction of a thiol bearing small molecule with a 5-amino functionalised 
oligonucleotide.'31"38 The disulphide monomer [41] (P59)  offers an alternative route 
which has a number of advantages over the existing methods. Firstly, no amino 
functionalisation of the oligonucleotide is required prior to addition. 	More 
importantly, the monomer can be added during solid phase oligonucleotide assembly. 
Deprotection to give the propyithiol is achieved in a simple process involving DTT 
with no extra step such as the addition of silver ions required. In addition, before 
cleavage, the thiol is constantly protected against dimerisation. The DMTr group 
permits the measurement of the coupling efficiency of the monomer which has been 
found to be consistently high yielding. Alternatively, if left on, it offers a means to 
assist purification during HPLC analysis in which the product oligonucleotide elutes 
much later than the failure sequences. In addition, the molecule can be introduced 
selectively at any site in an oligonucleotide sequence; DTT treatment always produces 
the terminal thiol group. 
To confirm that the product of DTT cleavage of an oligonucleotide containing 
the disulphide unit is a thiol, the oligonucleotide resulting from cleavage was treated 
with the thiol specific label, 5-iodoacetamidofluorescein (IAF)'39 [18] (p35, Figure 
2.35), for 5 hours at room temperature in DMF. 	On this occasion, the 
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Figure 2.35 5-lodoacetainidofluorescein Reaction 
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Following repeated gel filtration steps to ensure the complete removal of 
unreacted IAF molecules, the product was analysed on reverse phase HPLC (Figure 
2.36, Gradient 2, p120) and compared to the 5-terminal propyithiol monomer 
(Figure 2.37) which had been purified prior to DTT cleavage (i.e. while still carrying 
a DMTr group) and therefore separated from its failure sequences. The peak 
representing the thiol functionalised oligonucleotide (A) diminished and the product 
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Figure 2.37 : (SS + 18iner) + DTT 
87 
The ratio of product to starting material (approximately 5:1) shows how well the 
reaction ho. gone. No reaction occurred between IAF and an uncleaved disulphide 
containing oligonucleotide, nor was there any reaction between the failure sequences 
from the 5-terminal disulphide 18mer synthesis and IAF; therefore proving that no 
disulphide reduction occurs during deprotectiori at all. 
This offered a more conclusive method joc testing the product of disulphide 
cleavage than Eliman's reagent (Figure 2.38) which undergoes disulphide cleavage in 
the presence of thiols to give a bright yellow colour. ElIman's reagent offers a quicker 
but less reliable test - it also reacts with P(11I) containing compounds - although it 
has been used successfully a iiurnber of times during this work. 
COH 	CO2H 
02N 	
S - S 	
NO2 
Figure 2.38 : Ellinan 's Reagent 
The disulphide unit [31] (p82), as has already been shown, can be introduced at 
the 3-terminus of an oligonucleotide. Thus a route is also available for the synthesis 
of 3-terminal thiols. However, as several methods already exist for the synthesis of 
such oligonucleotides using similar chemistry, 124-127 this is less significant than the 
method developed for the synthesis of 5-thiols using the monomer [41]. 
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2.3 Oligonucleotides Containing 5'-Phosphates 
The synthesis of oligonucleotides by the standard methods yield a product 
with a free 5'-hydroxyl group after deprotection. However, many biological processes 
such as total gene synthesis, chemical ligation or structural studies require 
oligonucleotides bearing a 5-phosphate group. It has already been shown that the 
product of the cleavage of the disulphide group of monomer [41] when contained in 
an oligonucleotide was a propylthiol. It was decided to use the same general 
methodology to produce a monomer which results in a phosphate group at the 
oligonucleotide terminus following disulphide reduction. It has been observed on a 
number of occasionsl2 2,13 that if the alkyl chain attached to a disulphide unit were 
only two carbons in length, the thiol which results from disulphide cleavage will, 
under basic conditions, give a phosphate by a 13-elimination mechanism (Figure 1.18, 
p29). For that reason, such a monomer was synthesised (Figure 2.39). 
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Figure 2.39 : C2 Disulphide Monomer 
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The disulphide containing compound [8] was synthesised according to the 
procedure of Asseline et at 126  from dithiodiethan-1,1'-ol. Phosphorylation was carried 
out in THE using 2-chiorophenyldichiorophosphate with the addition of 1.OM TEAB 
solution after 2 hours. 
The 31P-NMR spectrum showed only one 	product from the reaction and 
when coupling was attempted with the monomer [46] (C2SS) onto a dT sequence 12 
nucleotides in length using the standard protocol (0. I4mmol, 104mg of monomer in 
acetonitrile/pyridine) the coupling efficiency was measured at 94%. However, when 
another 2'-deoxythymidine residue was coupled onto the disulphide, the resulting 
oligonucleotide with the 5-DMTr group still attached but the o-chlorophenyl group 
removed, gave a trace on reverse phase HPLC (Figure 2.40, Gradient 2, p120) which 
seemed to suggest that a far lower coupling efficiency had occurred. Even a poor 
coupling onto the disulphide group by the phosphoramidite monomer could not 
account for it. 
B 	 A 
% MeCN 
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A: C2SS-dTl2 B : Failure Sequces 
Figure 2.40 C2SS + dT12 
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Further phosphorylation reactions were attempted but the same result was 
obtained although the exact ratio between the peaks of the product and the failure 
sequences was variable. Why the coupling efficiency values calculated always 
indicated a normal coupling of 94-95% while the evidence of the HPLC traces was 
apparently contradictory was uncertain. Successful DTT cleavage of the product 
(peak A) to give a peak which eluted at a time similar to that of the failure sequences 
(peak B) and gave a positive result with Elimans reagent confirmed that the expected 
oligonucleotide had indeed been synthesised. It was initially thought that perhaps the 
poor couplings were for some reason a feature of this particular monomer but when 
the same result was obtained for a subsequent synthesis of the monomer [41] (p59), it 
seemed to suggest that there was a problem with the coupling procedure itself. The 
double distillation of the pyridine was repeated, the MSNT was analysed by 1H-NMR 
and mass spectrometry to confirm that its purity was high and modifications to the 
coupling procedure were attempted, all without avail. A sample treated at 550C for 
two days in ammonium hydroxide gave the identical HPLC trace to that after 5 hours 
at 550c;  confirming that the monomer is stable to the deprotection conditions and no 
post-synthetic decomposition was occurring. Curiously, when mixed base sequence 
oligonucleotides of 15-20 residues in length were reacted with the disulphide 
monomer, upon HPLC analysis, even lower quantities of product were observed. 
This was independent of whether the 5'-nucleotide was dT, dC, dA or dG. 
It was only when the 1H-NMR spectrum for a sample of the monomer [46] 
was examined more closely that a possible answer was discovered. The relative size 
of the TEA signals in the spectrum were greater than expected for a simple 
triethylammonium salt. Clearly, if there was any TEA present in the coupling 
solution, it would have an inhibitive effect on the coupling reaction. When the 
monomer [46] was coupled Onto a dT I Smer sequence once again, the reaction was 
carried out with double the quantity of monomer. The disulphide unit was not 
detritylated and HPLC analysis of the product (Figure 2.41, Gradient 2) following 
91 
deprotection gave an even poorer yield. Increasing the quantity of the monomer 
should have little effect on the coupling efficiency by itself, but if the TEA content of 
the monomer solution was doubled correspondingly, the yield would be reduced as 
indeed was observed. 
% NIcCN 
15.00 	20.00 	25.00 	30 
Time (lOins.) 
A: C2SS-dTl2 B : Failure sequences 
Figure 2.41 :(2 x C2SS) + dT15 
Triethylamine is a necessary component in the silica-gel flash column 
chromatography purification of the phosphotriester monomers in order to maintain the 
monomers as their triethylammonium salts. In this way, the exact TEA content of the 
monomers would vary thus accounting for the erratic nature of the H.PLC traces being 
obtained. 
Until this problem arose, TEA was removed from the purified phosphotriester 
monomers by overnight drying of the monomers in a vacuum desiccator. The 
phosphorus pentoxide drying agent in the desiccator was replaced with fresh drying 
agent and a sample of the phosphotriester monomer [46] was subjected to prolonged 
vacuum desiccation. A standard coupling reaction onto a dT 15mer oligonucleotide 
was performed with the re-dried sample and the HPLC analysis of the product 
oligonucleotide with the DMTr group still attached and the o-chlorophenyl group 
removed (Figure 2.42, Gradient 2) confirmed a favourable ratio of product to failure 
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Figure 2.42 C2SS + dTIS 
When the sample of monomer [41] which had previously been giving low 
coupling efficiency was subjected to the same drying treatment, the HPLC analysis 
once again indicated a high coupling efficiency. In addition, the coupling of monomer 
[46] onto a mixed base sequence proceeded smoothly (HPLC analysis). 
Every phosphotriester monomer used henceforth was subjected to careful 
drying prior to use. 	There was a possibility that the cholesterol containing 
phosphotriester monomers [42] (p74) and [43] (p75) prepared previously were 
contaminated with TEA. This would account for the very poor coupling efficiencies 
obtained for these monomers. However, in these cases, the monomers were in the 
form of solids thereby easier to dry. Also, elemental analyses of these molecules were 
close to the expected C, H and N content. This therefore seems unlikely. 
The reported protocol to reduce the disulphide group in an oligonucleotide to 
a phosphate varies widely, from 90 minutes at room temperature 136  to 6 hours at 
55°C' 26 or 16 hours at 55°C,' 25  all using DTT in ammonium hydroxide. The key 
factor is the rate of mercaptoethanol elimination once the disulphide has been reduced 
to the thiol. Is prolonged heating required or does the elimination reaction occur 
spontaneously at room temperature? 
The dT 15mer with the disulphide monomer [46] coupled to its 5-terminus 
(peak A, Figure 2.42) was treated with DTT in ammonium hydroxide both for 1 hour 
at room temperature - the standard disulphide cleavage conditions - and for 3 hours 
at 650C. Subsequent HPLC analysis of the gel filtered products (Figures 2.43, 2.44, 
Gradient 2) showed little difference between the samples. A dT 15mer sequence was 
synthesised with the addition of the standard phosphate monomer [19] (p35) onto its 
5-terminus. The resulting 5-terminal phosphate (Figure 2.45) was run as a mixed 
sample with the two products of DTT treatment (Figure 2.46). The unambiguous 
single peak obtained seemed to indicate that the identity of all three oligonucleotides 
was the same. 
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Figure 2.44: (G2SS-dTl5) + DTT (3 hours) 
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Figure 2.45: [19] + dT15 
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Figure 2.46: Mixed Sample 
However, it has already been observed that reverse phase HPLC is not always 
capable of separating oligonucleotides with a small difference in lipophilicity, for 
example with and without an alkyl chain of only two carbons in length. Capilliary 
zone electrophoresis (CZE) separates oligonucleotides based on their charge content 
in addition to their lipophilicity. The high sensitivity of this technique should be 
sufficient to distinguish between a 5-terminal phosphate and a 5-terminal thiol of an 
oligonucleotide of the same base sequence. 	The difference between the 
oligonucleotide still with the disulphide group intact and bearing a 5'-DMTr group 
(Figure 2.47, peak A) and the product of DTT treatment for 1 hour at room 
temperature (Figure 2.48, peak B) was clear. When the conventionally synthesised 
5-phosphate was analysed (Figure 2.49, peak C), the product peak had an identical 
elution time to the product of disuiphide cleavage. A mixed CZE sample of all three 
of the above (Figure 2.50, A + B + C) showed the difference between the disulphide 
containing oligonucleotide which eluted last and the other two oligonucleotides which 
again were present as one unambiguous peak. 
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DMTr-dT15 
Figure 2.47: C'2SS-dTl5 
phosphate-dT15 
Figure 2.48: (c2SS-dTl5) + DTT (1 hour 
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Figure 2.49: [19] + dTl5 
B + C 	A 
A: DMTr-dT15 B + C : phosphate-dT15 
Figure 2.50 : Mixed Sample 
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As a final experiment, it was decided to react the oligonucleotide obtained 
from the disulphide reduction reaction above with IAF. The procedure was identical 
to that used for reaction between IAF and the 5'-terminal thiol oligonucleotide 
obtained using monomer [41] (see Section 2.2, p85). On this occasion, there was no 
evidence whatsoever for any reaction having occurred, showing that there was no 
thiol present at all in the sample. The HPLC trace of the product (Figure 2.51, 
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Figure 2.51 : (C2SS-dTl5 + DTT) + JAF 
From the evidence, it seemed extremely likely that the desired 5-terminal 
phosphate was the product after the oligonucleotide bearing the disulphide unit [81 
(p89) was treated with DTT in base. Thus an alternative to the phosphate monomer 
[19] (p35) has been developed, also added during solid phase oligonucleotide 
assembly but compatible with the phosphotriester coupling approach. In addition, the 
monomer [46] (p89) presents an alternative to the monomer [41] (P59)  as a source of 
a cleavable linker to be coupled to the 5-teim111us of an oligonucleotide. 
2.4 Oligonucleotides Containing a Cleavable Biotin 
Oligonucleotides can be hiotinylated prior to their application in the polymerase 
chain reaction (PCR) to enable the amplified products to be isolated (on streptavidin). 
However, the binding between the biotin and streptavidin is so tight (Kd = 10 5M) 
that problems are encountered freeing the oligonucleotides. The only method 
currently available for the release of a biotin labelled oligonucleotide captured on 
streptavidin is to use the cleavable biotin 2'-deoxyuridine triphosphate [15] (Figure 
1.20, 	p32),132 	developed 	from 	sulphosuccinimidyl-2-(biotinamido)ethyl- 1,3'- 
dithiopropionate (NHS-SS-Biotin) [14] (p32).  It contains a disulphide linker between 
the biotin and a 2-deoxyuridine base which is cleaved by DTT. However, the 
synthesis of such a monomer involves a three step base modification procedure and 
the resulting modified 2-deoxyuridine triphosphate can be incorporated into an 
oligonucleotide by the non-selective nick-translation technique or other enzymatic 
methods. The employment and extension of the disulphide phosphotriester chemistry 
developed above offers potentially superior methods for the incorporation of 
cleavable biotin molecules into oligonucleotides; the synthesis procedures are 
straightforward and the monomers can he added to the 5-terminus of oligonucleotides 
during solid phase assembly. 
The first method used for biotinylating an oligonucleotide via a cleavable linker 
was the straightforward coupling of the biotin phosphoramidite monomer [24] 
(Figure 1.28, p4O) onto a disulphide functionalised oligonucleotide. A dT sequence 6 
nucleotides in length was synthesised and the disulphide phosphotriester monomer 
[41] was added as before. Following capping and detritylation, the biotin monomer 
was added using a standard automated coupling cycle. The DMTr and o-
chlorophenyl groups were removed and the product was analysed on reverse phase 
HPLC (Figure 2.52, Gradient 2, p120). The target oligonucleotide (peak A) 
appeared as a larger peak than the failure sequences (peak B). 
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Figure 2.53 : (Biotin-SS-dT6) + DTT 
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Figure 2.54 : Biotin-SS-M + HS-dT6 
Once isolated, the product oligonucleotide was treated with DTT, without any 
subsequent gel filtration step as it was only 6 nucleotides in length (Figure 2.53). 
The cleaved oligonucleotide (peak C) lay between the failure sequences (B) and the 
starting oligonucleotide (A). The residual DTT eluted far earlier (peaks D and E). 
An analysis of a mixed sample of the above (Figure 2.54) showed the difference 
between the original oligonucleotide (A) and the cleaved product (C). A positive 
result with Ellmans reagent confirmed that a thiol was the product of cleavage. 
However, the coupling efficiency of the biotin phosphoramidite monomer (59%) 
was substantially reduced from standard (97%), even more than previously observed 
for a coupling onto a 5'-disulphide unit. Although the above method is still a valid 
synthetic route to cleavable biotin oligonucleotides, it was thought desirable to 
develop another method possessing potentially higher yields. A biotin phosphotriester 
monomer could have been synthesised hut after the poor results of the two cholesterol 
derived phosphotriester monomers [42] (p74) and [43] (p75), it was decided to 
synthesise and phosphorylate a molecule containing both the biotin and disulphide 
groups. 
Initially, an amino functionalised disulphide unit was synthesised (Figure 2.55) 
analogously to before (Figure 2.8, p54) with t-butyldimethylsilyl (TBDMS) as the 
hydroxyl protecting group to allow the DMTr protecting group to be used to protect 
the Y position of the biotin molecule. The disulphide containing diol [30] was 
protected at a single hydroxyl group by reaction with one equivalent of t-
butyldimethylsilyl chloride in pyridine. The available hydroxyl group of the product 
[47] was reacted with tosyl chloride in pyridine. During this step, compound [47] 
appeared to be far more hyroscopic than the analogous DMTr protected molecule 
[33] (p54) and so extra precautions involving careful distillation of the solvents and 
vacuum desiccation of [47] were taken to ensure anhydrous conditions and to avoid 
the oxidation of rosyl chloride to tosic acid. The tosylate group of [48] was then 
displaced by potassium phthalimide in DMF. 
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Figure 2.56: Clearable Biotin Monomer 
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Conversion of the phthalimide [49] to the amine [50] was carried out with hydrazine 
hydrate in a (1:1) dichloromethane/methanol mixture. 
(+)Biotin-2-nitrophenylester was prepared by the procedure of Sproat et al.' 57 
The 1 position of the biotin ring was then protected by reaction with 4,4'-
dimethoxytrityl chloride in pyridine. The reaction between the protected biotin active 
ester [51] and the disulphide amine [50] (Figure 2.56) in DMF in the presence of 
TEA proceeded only very slowly. The product [52] was isolated after 5 days. 
Removal of the silyl protecting group by treatment with tetrabutylammonium fluoride 
solution (1 .OM in THF) yielded the compound [53]. However, phosphorylation to 
give the monomer [54] did not work as cleanly as in previous examples. The yield 
was only moderate (48%) and the 31 P-NMR spectrum contained only a weak signal 
and a high level of noise, even after precautions had been taken to remove all residual 
TEA present. 
When the monomer (Biotin-SS) was added to a dT 15mer sequence in the 
standard ron-automated procedure (0. l4mniol, 140mg of monomer in 
acetonitrile/pyridine) a coupling efficiency of only 45% was obtained. This was 
reflected in the HPLC analysis (Figure 2.57, Gradient 2) although when the product 
oligonucleotide (peak A) was treated with DTT, cleavage was once again quantitative 
to give an earlier eluting peak (C, Figure 2.58), which reacted with Eliman's reagent. 
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Figure 2.57 : Biotin + dT15 
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Figure 2.58 (Biotin + dT15) + DTT 
It seems likely that the relatively poor coupling efficiency of the monomer [54] 
was a reflection of the poor phosphorylation reaction, rather than the presence of any 
TEA. Nevertheless, the one addition reaction carried out indicated the potential 
usefulness of this route to a cleavable biotin monomer and if the procedure were 
optimised, it could prove extremely valuable. Furthermore, using the shorter C2 
disulphide unit, a cleavable biotin monomer could be developed in which the product 
of the cleavage reaction was a 5-terminal phosphate instead of a 5-terminal thiol. 
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2.5 Oligonucleotides Containing a Cleavable Aminolinker 
There is a great demand for the synthesis of oligonucleotides bearing a 5'-
terminal amino functionality. The amino group is more reactive than the hydroxyl 
group and offers an easy means for the attachment of a variety of different labelling or 
reporter groups. A cleavable aminolink at the 5-terminus of an oligonucleotide 
would enable the oligonucleotide to be detached from the labelling group once the 
labelling molecule was no longer required. As yet no cleavable aminolink monomers 
have been developed. The phosphotriester coupling chemistry described above can 
easily be extended to the synthesis of such a monomer, attachable during solid phase 
oligonucleotide assembly. 
For the synthesis of the arninolink monomer, it was decided to use DMTr as the 
amine protecting group. When attached to primary amines, the DMTr group is far 
more labile than when used as a hydroxyl protecting group due to the increased 
propensity of the amine to protonation. However, if precautions are taken to speed 
up the purification procedure and to maintain a basic environment throughout, this 
type of compound can be handled, although with reduced reaction yields because of a 
certain amount of unavoidable detritylation. The advantage of using the DMTr group 
is that the coupling efficiency for the cleavable aminolink monomer can be accurately 
calculated instead of having to estimate it from HPLC analysis. 
The TBDMS protected amino disulphide molecule [50] was reacted with 4,4-
dimethoxytrityl chloride in pyridine (Figure 2.59). The product [55] was deprotected 
at the hydroxyl group by treatment with tetrabutylammonium fluoride solution (1.OM 
in THF) to give compound [56]. This was then phosphorylated in THF with 2-
chlorophenyldichlorophosphate to give the phosphotriester monomer [57]. 
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Figure 2.59 : Cleavable Arninolink Monomer 
107 
As expected, the yields for each step in the reaction scheme were relatively poor 
due to detritylation. However, the phosphotriester monomer which resulted [57] had 
a promising 31P-NMR spectrum and when coupling was attempted after removal of 
any residual TEA (0.14mrnoI, 109mg of monomer in acetonitrile/pyridine) onto a 
detritylated dT I 5mer sequence, the measured coupling efficiency for the monomer 
was extremely encouraging (85%). Although the absence of a protecting group made 
the product oligonucleotide indistinguishable from the failure sequences during HPLC 
analysis (Figure 2.60, Gradient 3, p120) and DTT treatment foliwed by gel filtration 
gave a peak with the identical elution time (Figure 2.61), testing with the amino 
sensitive ninhydrin spray was more revealing. The oligonucleotide with the intact 
disulphide aminolink turned a dark blue colour when sprayed with riinhydrin on a tic 
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Only once was coupling attempted but it showed considerable promise. If the 
coupling procedure is optimised, it is likely that even higher coupling efficiencies will 
be possible. The DMTr group used in these initial studies enabled the coupling 
efficiency of the monomer to be measured but as a protecting group it was barely 
adequate. For the future development of this cleavable arninolink, a more stable 
protecting group such as 4-monomethoxytrityl (MMTr) or trifluoroacetyl would have 
to be used. In particular, the ABI 394 DNA synthesiser measures nityl yields by 
conductivity, treating DMTr and MMTr equally and it is therefore possible to 
accurately measure MMTr coupling efficiencies on this machine. As amino 
functionalised oligonucleotides are often used for biotinylation,'46"51 '54 this cleavable 
aminolink monomer offers a third route to cleavable biotin containing 
oligonucleotides, a possibility which could be investigated, along with its reaction 
with other amino specific labels. In addition, the TBDMS protected molecule [56], an 
intermediate in the synthesis of both the cleavable biotin and cleavable aminolink 
monomers, [54] and [57], could also have been used to synthesise the cleavable 
lipophilic molecules [37] (p55) and [39] (p56) with subsequent phosphorylation. 
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Clearly, however, the described route to cleavable aminolink monomers, with 
the disulphide group as the cleavable entity, has been shown to have merit. Once a 
monomer is developed, the alternative C2 linked disulphide unit could be treated in a 
manner analogous to the C3 disulphide unit; the product of cleavage could therefore 
be a terminal phosphate. 
3 EXPERIMENTAL 
3.1 General Procedures 
Solvents and reagents 
All solvents were of laboratory grade except those used for phosphoramidite 
extraction and purification when all solvents were of HPLC grade. Anhydrous 
dichiorometh ane, anhydrous triethylamine, anhydrous pyridine and anhydrous dioxane 
were prepared by distillation from calcium hydride. Doubly distilled pyridine was 
prepared b\ distillation from potassium hydroxide then calcium hydride. Anhydrous 
tetrahydrofuran was prepared by distillation from sodium/benzophenone. Anhydrous 
N,N-dimethylformamide was obtained by fractional distillation from molecular sieves. 
Anhydrous hexane and diethyl ether were dried over sodium wire, diisopropylarnine 
was dried over calcium hydride. Anhydrous acetonitrile and 5% trichloroacetic acid 
in dichloromethane were purchased from Applied Biosystems Ltd.. 	1M 
Triethylammonium bicarbonate solution was prepared by bubbling dry carbon dioxide 
through 34.7m! of triethylamine in 200m1 water overnight then diluting with water to 
a 250m1 volume. 
4,4-Dimethoxytrityl chloride was purchased from Courtaulds, 3-
hydroxypropionitrile and 4-dimethylaminopyridine from Fluka, potassium phthalimide 
from Lancaster Synthesis, hydrazine hydrate and 2-nitrophenol from Fisons and 1-
hydroxy-6-trifluoromethylbenzotriazole from Cambridge Research Biochemicals Ltd.. 
All other reagents were purchased from Aldrich. p-Toluenesulphonyl chloride was 
purchased from Aldrich and recrystaflised from 40-60 petroleum ether/chloroform. 
Chromatography 
Flash column chromatography was carried out using silica-gel 60 supplied by 
Fluka. When the compound to be purified contained a component vulnerable to acid 
attack, such as phosphoramidite groups or 4,4-dimethoxytrityl protected 
functionalities, the silica-gel was first washed with triethylamine in an appropriate co- 
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solvent. This neutralised all the acidic groups present on the silica-gel. Purification in 
the appropriate eluant could then proceed. For the phosphotriester monomers, in 
addition to priming with triethylamine, triethylamine was also added to the eluent 
during purification in order to maintain the monomers as their triethylammonium salts. 
Thin layer chromatography (tic) was carried out on aluminium sheets coated 
with silica 60, F254, 0.2mm layer from Merck using the following solvent systems: 
A 	Ethyl acetate:Diethyl ether (1:1) 
B 	Hexane:Diethyl ether (1:1) 
C Hexane:Ethyl acetate (1:1) 
D Dichloromethane:Methanol (9:1) 
E Toluene:Methanol (9:1) 
F 	Ethyl acetate: Methanol:Ammonia (5:1:1) 
Products were visualised on tic using ultraviolet (UV) absorption at 264nm, 
phosphomolybdic acid (10%) in ethanol (dark blue colour in the presence of 
oxidisable compounds), an iodine tank (yellow stain in the presence of oxidisable 
compounds), ninhydrin spray (3% in ethanol, blue/black colour in the presence of 
amines) or Eliman's reagent [0.1% solution of dithio-bis-2-nitrobenzoic acid in 
ethanol/0.45M Tris buffer (1:1): bright yellow colour in the presence of thiols]. 
Nuclear Magnetic Resonance Spectra (NMR) 
'H-NMR spectra were recorded on a Brucker WH360 (360MfIz), a Brucker 
WP200 (200.13MHz) or a Brucker WP80 (80MHz) spectrometer. 13C-NIMR 
spectra were recorded on a Brucker WH360 (90.6MHz) or a Brucker WP200 
(50.32MHz) spectrometer. Trimethylsilane was used as internal reference and cited 
chemical shifts are given in ppm downfield to this standard. 31P-NMR were recorded 
on a Brucker WP200 (81MHz) or a Jeol FX90Q (36MHz) spectrometer with 
phosphoric acid (8 0.00) as an external reference. All samples were run in the solvent 
indicated. 
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Mass Spectra (MS) 
Fast atom bombardment (FAB) mass spectra were recorded on a Kratos 
MS50TC mass spectrometer in a matrix of thioglycerol or 3-noba (3- 
nitrobenzylalcohol). 
Infrared Spectra (IR) 
Infrared spectra were recorded on a Biorad FTS-7 Fourier Transform IR 
spectrophotometer using KBr plates and a polystyrene reference (1603cm 1 ). Samples 
were used undiluted or as a nujol mull. 
CHN Microanalyses 
CHN Microanalyses were carried out on a Perkin Elmer 240 elemental analyser. 
Melting Points (MP) 
Melting Points were carried out on a Kofler Hotstage apparatus and are 
uncorrected. 
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3.2 Oligonucleotide Synthesis, Analysis and Purification 
Oligonucleotide Synthesis 
Oligonucleotide syntheses were performed on Applied Biosystems 380B or 394 
DNA synthesisers on a 0.2 or ltrnole scale. Standard cyanoethyl phosphoramidite 
monomers for DNA synthesis were supplied by Applied Biosystems Ltd., biotin 
monomers were supplied by Cambridge Research Biochemicals Ltd. and all 
monomers were used at a concentration of 0.1M in anhydrous acetoniile. All other 
DNA synthesis reagents were supplied by Applied Biosystems Ltd.. Sephadex G25 
NAP-10 (nucleic acid purification) columns were supplied by Pharmacia. For 
phosphorothioate oligonucleotide syntheses, iodine was replaced by tetraethylthiuram 
disulphide (TETD). Reverse osmosis purified sterile water was used at all stages of 
oligonucleotide synthesis, analysis and purification. 
The overall yield of purified oligonucleotide in milligrams or micromoles can be 
determined from the UV absorbance of an aqueous solution of the oligonucleotide. 
Hence oligonucleotide quantity is often quoted in terms of optical density (OD) 
values. 
Measurement of Coupling Efficiencies 
Coupling efficiencies were measured by comparison of the absorbance at 495nm 
of the 4,4'-dimethoxyttityl cation produced in the detritylation steps of successive 
synthesis cycles. Absorbances were measured after diluting the individual trityl 
samples to 25m1 with 0.1Mp-toluenesulphonic acid in acetonitrile. 
Coupling of the Lipophilic Monomers 
All lipophilic monomers were used as 0. 1M solutions in anhydrous 
dichloromethane. 	In order to increase the coupling yields of the lipophilic 
phosphoramidites, delivery times for the addition of these monomers were increased 
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to 4 seconds (from 2 seconds), coupling times were increased to 5 minutes (from 30 
seconds) and oxidation times were increased to 15 minutes (from 30 seconds). In all 
cases an additional dichlorornethane wash step before and after the coupling step was 
included in the synthesis cycle to prevent precipitation of the monomer and blockage 
of the reagent lines. 
For the hexaethyleneglycol and hexadecyl monomers containing the 4,4'-
dimethoxytriyl group, coupling efficiencies were measured directly on the DNA 
synthesiser via the Trityl-Off configuration. 	For the cholesterol, 1,2-di-0- 
hexadecyiglyceryl and related monomers, coupling efficiencies were deduced by 
removing the capping step from the synthesis cycle of the lipophilic monomer 
addition, calculating the coupling efficiency of a further addition of a standard 
phosphoramidite monomer (e.g. dT) onto the unreacted 5'-hydroxyls of the 
oligonucleotide (assuming a standard coupling of 98.5% for the standard monomer). 
Coupling of the Phosphotriester Monomers 
All phosphotriester monomers were coupled onto a dethtylated (5' Trityl-Off) 
support hound oligonucleotide by a non-automated procedure in the quantities 
indicated below (Table 3.1). 
Triester Compound 41 42 43 46 54 57 
mass (mg) 108 94 115 104 140 109 
The monomer (0.1 4mmol) and 1- (2-mesitylenesuiphonyl)- 1 ,2,4-triazole (MS NT, 
3eq., 0.42mmol, 123mg) were dissolved in an anhydrous acetonitrile (anhydrous 
tetrahydrofuran for the cholesterol monomers)/doubly distilled pyridine mixture (9:1, 
0.20m1) and were injected manually onto the DNA synthesis column. Following 
Table 3.1 
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intermittent agitation for 90 minutes, the column was washed repeatedly with 
anhydrous acetonitrile (or anhydrous tetrahydrofuran for the cholesterol monomers) 
then returned to the DNA synthesiser for all subsequent detritylations and couplings 
and for cleavage from the solid support. 
Cleavage of the Disulphide Oligonucleotides 
Following removal of the solvent under vacuum, the oligonucleotides were 
dissolved in 0.1 ml of 0.1 M ammonium acetate solution to which was added 0.2m1 of 
aqueous amnionia and dithiothreitol (DTT, 50mg, 0.32mmol). The solution was left 
at room temperature for 1 hour then the oligonucleotide was purified by gel filtration 
using a Sephadex G25 NAP-10 column. Analysis and further purification were 
performed by HPLC as required. 
Reaction of Thiol Oligonucleotide with 5-Iodoacetamidofluorescein139 
Approximate 4.00D units of the thiol oligonucleotide were dissolved in 0.3m1 
of 0.2M Tns/HC1 buffer (pH 7.2-8). 5-lodoacetamidofluorescein (3mg) was 
dissolved in anhydrous N,N-dimethylformamide (0.3m1) and added to the 
oligonucleotide. At this point the solution turned bright orange. After being left in 
the dark for 5 hours at room temperature, the mixture was purified twice by gel 
filtration using Sephadex G25 NAP-10 columns. Analysis was carried out on HPLC. 
Derivatisation of Controlled Pore Glass (CPG) solid support 
1. Activation 
3-Aminopropyl CPG (0.5g) was slowly shaken in trichloroacetic acid (5% in 
dichloromethane, 5m1) for 2 hours at room temperature. The solution was filtered off 
and the glass beads washed successively with u-iethylamine/diisopropylethylamine 




The activated CPG (0.5g) was mixed with succinic anhydride (immol, 100mg) 
and 4-dimethylaminopyridine (0.33rnmol, 40mg) in 4m1 of anhydrous pyridine. After 
being slowly shaken for 18 hours at room temperature, the mixture was filtered and 
the glass beads washed successively with pyridine, dichloromethane and diethyl ether. 
The resin was then dried under vacuum for 90 minutes. 
Functionalisation 
A sample of the succinylated CPG (0.25g) was mixed with compound [31] 
(p50, 0.07mmol, 34mg), 4-dimethylaminopyndine (0.025mmol, 3mg) and 1-(3-
dimethylaminopropyl)-3-ethylcarbodiirnide hydrochloride (0.5mmol, 96mg) in 6rril of 
anhydrous pyridine. After being slowly shaken for 18 hours at room temperature, the 
mixture was filtered and the glass beads washed successively with pyridine, 
dichloromethane and diethyl ether. The resin was then dried under vacuum for 90 
minutes. 
Desuccinylation 
To removed the unreacted succinylate groups, the functionalised CPG was 
slowly shaken with piperidine (5m1) for 5 minutes at room temperature. The glass 
beads were then filtered, washed successively with pyridine, dichloromethane and 
diethyl ether and dried under vacuum for 90 minutes. 
Trityl Test 
To measure the degree of function alisation, the absorbance of the trityl colours 
was measured. Approximately 5mg of functionalised resin were suspended in 
trichloroacetic acid (5% in dichloromethane, 10ml) and the absorbance was measured 
at 504nm. The amount of bound monomer in tmol.g 1 of support (c), is given by: 
c = absorbance at 504nm x volume (nil) of trichloroacetic acid solution x 13.2 
mass of resin (nig) 
Absorbance measured = 2.38; mass = 5.4mg; therefore C = 58.0tmol.g 1  
6. Capping 
To cap the unreacted amino functions, the CPG was mixed with N-methyl-
imidazole (0.75m1) and acetic anhydride (1.65m1) in anhydrous tetrahydrofuran (4m1) 
and slowly shaken for 2 hours at room temperature. The glass beads were filtered 
then washed successively with pyridine, dichioromethane and diethyl ether. The resin 
was then dried under vacuum for 90 minutes. 
This gave 184mg of functionalised CPG resin to be loaded into a synthesis 
column and used in automated DNA synthesis. 
High Performance Liquid Chromatography (HPLC) 
The fully deprotected oligonucleotides were analysed and purified by reverse 
phase HPLC on a Gilson 306 system using a Brownlee Aquapore Octyl (C8) reverse 




Time (minutes) 0 2 20 27 28 30 
%B 0 0 I 	100 100 0 0 
A = 0.1M trieth yl ammonium acetate solution 
B = 80% acetonitrile in 0.1M triethylammonium acetate solution 
Gradient 2 
Time (minutes) 0 2 3 20 22 27 28 30 
%B 0 0 15 50 100 100 0 0 
A = 0.1M arnrnonium acetate solution 
B = 50% acetonitrile in 0.1M ammonium acetate solution 
Gradient 3 
Time (minutes) 0 2 3 24 25 27 28 30 
%B 0 0 1550j100100I 0 0 
A = 0.1M ammonium acetate solution 
B = 2517o acetonitrile in OJM ammonium acetate solution 
Oligonucleotide type Lipophilic Trityl-On/Bioti n Trityl-Off 
Gradient 1 2 3 
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The gradients and acetonitrile concentrations used were reflective of the 
lipohiicity of the synthesised oligonucleotides. The UV monitor was set at a value 
between 264nm and 295nm depending on the length and quantity of the 
oligonucleotide being analysed. In most cases the desired oligonucleotides eluted 
several minutes after the failure sequences. If required the oligonucleotides were 
further purified by gel filtration using Sephadex G25 NAP-10 columns and then 
lyphophilised. 
Capilliary Zone Gel Electrophoresis (CZE) 
Further analysis of oligonucleotides by CZE were conducted on an Applied 
Biosystems Model 270A automated electrophoresis system with MicroGel capillaries. 
The following conditions were used: 
Buffer = 75mM Tris-phosphate/10% methanol, pH 7.5; 
Loading voltage = -5kV; 	Temperature = 30°C; 	Samples = 5.tM in water; 
Running voltage = - I 5kV,  Detector = 260nm. 
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nC16H330 	 O 
To a stirred solution of bis(p-nitrophenyl)carbonate (2eq., 2mmol, 0.61g) in 
anhydrous dichioromethane (lOmi), a solution of 1,2-di-0-hexadecylglycerol (leq., 
immol, 0.540 in anhydrous dichioromethane (lOmi) was added dropwise. 1,8-
Diazabicyc1o5.4.01undec-7-ene (2eq., 2mmol, 0.30m1) was then added. After stirring 
at room temperature for 18 hours, the mixture was then diluted with dichioromethane 
(30ml), washed with brine (3 x 30m1) then citric acid (3 x 30m1), at which point the 
organic layer became neutral. After drying over anhydrous sodium sulphate and 
removal of the solvent by evaporation, the product was purified by silica-gel flash 
chromatography, eluting with hexane:diethyl ether (1:1) to give a waxy, white solid. 
Yield 1.00g (71%). Rf 0.87 (system B). MP 36-370C. Umax(flm)/cm' 2958 
(s), 2915 (s), 2848 (s), 1765 (s, CO), 1593 (w), 1524 (m), 1468 (m), 1349 (m), 1259 
(s), 1217 (s). 1091 (s), 1018 (s), 861 (m), 798 (s). FAB mass spectrum: nVz 706.5572 
[calc. for C42h76N07 (M + 1): 706.56211. 'H-NMR (CDC13): S 0.83-0.90 (t, 6H, 
2CH3 Cl 6 J=6.4Hz); 1.24 (s, 60H, 30CH2); 3.39-3.72 (m, 5H); 7.35-7.39 (d, 2H, 2, 
6 CH nitrophenyl, 123=9.2Hz); 8.24-8.29 (d, 2H, 5, 3 CH nitrophenyl, J32=9.2Hz). 
13C-NMR 'CDC13): 5 13.99 (2CH3); 22.57 (2CH2); 25.97 (2CH2); 29.25 (2CH2); 
29.36 (2CHi); 29.57 (18CH2); 31.81 (2CH2); 68.68 (CH20); 69.41 (CH20); 70.69 
(CH20); 71.75 (CH20); 76.00 (CH0); 121.62 (2ArCH); 125.15 (2ArCH); 145.22 
(ArC); 152.37 (ArC); 155.47 (CO). Analysis: 71.53% C, 10.85% H, 2.28% N (caic. 
for C42H75N07: 71.45% C, 10.71% H, 1.98% N). 
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1-[(1,2-Di-0-hexaclecylglyceroxy)ca rbonylamino] hexan-6-ol [28] 





Compound [27] (leq., 1.34mmol, 0.95g) was dissolved in anhydrous 
dichioromethane (6m1) to which was added 6-aminohexan-1-ol (1.leq., 1.4mmol, 
0.16g) and anhydrous triethylamine (l.leq., 1.4mmol, 0.20m1). After stirring at room 
temperature for 19 hours, the solution was diluted with dichioromethane (30ml) then 
washed with brine (3 x 30iiil) and water (30m1). After drying over anhydrous sodium 
sulphate and concentration by evaporation, the residue was purified by silica-gel flash 
chromatography, eluting with hexane:ethyl acetate (1:1) to give a waxy, white solid. 
Yield 0.59g (64%). Rf 0.57 (system Q. MP 49-500C. Dmax(film)/cm 3331 
(s, OH), 2947 (s), 2918 (s), 2850 (s), 1686 (s, CO), 1534 (m), 1511 (s), 1376 (s), 
1339 (w), 1286 (m), 1250 (s), 1218 (w), 1110 (m), 1062 (m), 1034 (w), 1012 (w), 
720 (m). FAB mass spectrum: m/z 685 (M + 1). 1 H-NMR (CDC13): 60.82-0.88 (t, 
6H, 2CH3, C16, J=6.2Hz); 1.23 (s, 72H, 36CH2); 3.38-3.64 (m, 5H). 13C-NMR 
(CDC13): 6 13.99 (2CH3); 22.56 (2CH7); 25.16 (CH2); 25.95 (2CH2); 26.23 (2CH2); 
29.24 (2CH')); 29.57 (I8CH2); 29.86 (2CH7); 31.80 (2CH2); 32.39 (CH2); 40.72 
(CH2N); 62.51 (CH20); 64.07 (CH-?O); 70.23 (CH20); 70.46 (CH20); 71.66 
(CH20); 76.71 (CHO); 156.42 (CO). Analysis: 73.45% C, 12.44% H, 2.46% N (caic. 
for C42H85N05: 73.74% C, 12.52% H, 2.05% N). 
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2CyanoethyI-N,N-diiSOPrOPY1{1-[(1,2-di-0- 
hexadecylglyceroxy)ca rbonylaminolhexan-6-O} phosphoramidite [29] 
o nC16H33O l/"" 








Compound [28] (leq., 0.51g, 0.75mmol) was coevaporated twice with 
anhydrous dichioromethane then dissolved in anhydrous dichioromethane (8m1). 
Diisopropylethylamine (3eq., 2.25mmol, 0.29g, 0. 39ml) and 2-cyanoethyl-N,N-
diisopropylphosphoramidite'63 (1 .4eq., I .O5mmol, 0.25g, 0.24m1) were added. After 
stirring at room temperature for 24 hours, the reaction mixture was diluted with ethyl 
acetate, washed with brine then dried (anhydrous sodium sulphate) and concentrated 
under vacuum. The product was purified by silica-gel flash chromatography, eluting 
with anhydrous hexane:anhydrous diethyl ether (1:1) primed with 1% triethylamine. 
Yield 0. 8g (42%). Rf 0.43 (system B). FAB mass spectrum: ni/z 886 (M + 
3). 'H-NMR (CDC13): 6 0.82-0.89 (t, 6H, 2CH3 C16, ./=6.4Hz); 1.13-1.15 (d, 6H, 
2CH3 i-Pr, .1=2.3Hz); 1.17-1.18 (d, oH, 2CH3 i-Pr, .1=2.3Hz); 1.23 (s, 72H, 36CH2); 
2.59-2.65 (m, 2H, CH2CN); 3.37-3.64 (m, 7H); 3.77-3.84 (m, 2H, CH20). 31P-
NMR (CDC13): 6 147.67 (s). 
Dithiodipropan-1 ,1 '-ol [30] 
HO 	 S - S 	 OH 
3-Bromc'propan-1-ol (leq., 72mniol, lOg) and sodium thiosulphate (leq., 
72rnmol, 17.9g) were added to an ethanol/water mixture (1:1, lOOmi) and refluxed for 
30 minutes to allow a homogeneous solution to form. After cooling, iodine (leq., 
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72mmol, 9. ig) was added in small portions, at which point the violet colour remained. 
The reaction mixture was diluted with diethyl ether (50m1) and O.1M potassium 
chloride solution (50m1). The product was extracted into the organic layer with 
diethyl ether (4 x 50m1) and the combined extracts washed with 1M sodium sulphite 
solution (3 x 50m1) until colourless. After drying (anhydrous sodium sulphate) and 
removal of the solvent under vacuum, the product, a clear oil, did not require any 
further purification. 
Yield 5.35g (82%). Rf 0.46 (system D). Dmax(fi1m)/cm 3501 (s, OH), 3261 
(s, OH), 2930 (s), 2876 (s), 1642 (s), 1470 (m), 1433 (s), 1346 (m), 1283 (m), 1257 
(s), 1148 (rn), 1052 (s), 901 (s). FAB mass spectrum: m/z 182.0423 [calc. for 
C6H1402S2 (Mt): 182.04351. 1H-NMR (CDC13): ö 1.85-1.98 (quin., 4H, 2, 2' 
CH2, J=6.6Hz); 2.74-2.81 (t, 4H, 3, 3' CH, 1=7.lHz); 3.68-3.74 (t, 4H, 1, 1' CH2, 
J=6.lHz). 13C-NMR (CDC13): 31.59 (2CH2); 34.97 (2CH2S); 60.62 (2CH20). 
1-(4,4'-Dimethoxytrityloxy)dithiodipropan-l'-oI [31] 
DMTrO 	 S - S 	 OH 
Compound [30] (leq., 3.08g, 16.9mmol) was dried twice using anhydrous 
pyridine then dissolved in anhydrous pyridine (15m1) to which was added 4,4'-
dimethoxytrity1 chloride (leq., 16.9mrnol, 5.73g). After stirring at room temperature 
for 16 hours the reaction mixture was quenched with methanol (30m1) then evaporated 
to an oil which was coevaporated twice with toluene. The residue was taken up in 
dichioromethane (50m1), washed with brine (3 x 30m1) then dried (anhydrous sodium 
sulphate). The solvent was removed by evaporation and the product was purified by 
silica-gel flash chromatography, eluting with methanol in dichioromethane (0-4%) 
primed with 1% triethylamine. 
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Yield 4.51g (55%). Rf 0.36 (system E). Umax(film)/cm'  3409 (s, OH), 3055 
(w), 2951 (m), 2928 (s), 2835 (w), 1607 (s), 1580 (w), 1462 (m), 1443 (m), 1299 (m), 
1249 (s), 1176 (s), 1153 (w), 1066 (m), 1034 (s), 901 (w), 828 (s), 753 (m), 702 (m). 
FAB mass spectrum: m/z 485.1787 [caic. for C27H3304S2 (M + 1): 485.1820]. 
1H-NMR (CDC13): 5  1.90-1.97 (rn, 4H, 2, 2' CH2); 2.71-2.84 (m, 4H, 3, 3' CH); 
3.12-3.18 (t, 2H, I CH2, J=6.lHz); 3.68-3.74 (t, 2H, 1' CH2, J=6.lHz); 3.78 (s, 6H, 
20CH3); 6.79-6.85, 7.19-7.44 (m, 13H, ArH). 13C-NMR (CDC13): 8 29.58 (CH2); 
31.70 (CH2); 34.99 (CH2S); 35.61 (CH2S); 55.00 (20CH3); 60.58 (CH20); 61.46 
(CH20); 85.63 (C); 112.81 (4ArCH); 126.47 (ArCH); 127.56 (2ArCH); 127.91 
(2ArCH); 129.80 (4ArCH); 136.17 (2ArC); 144.95 (ArC); 158.13 (2ArC). 




DMTrO S_S O_P CN 
Compound [31] (leq., 0.96g, 1.98mrnol) was coevaporated twice with 
anhydrous dichioromethane then dissolved in anhydrous dichioromethane (lOmi). 
Diisopropylethylamine (3eq., 5.94mmol, 0.77g. 1 .03m1) and 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite163 (1 eq., 1 .98mmol, 0.47g, 0.44mmol) were added 
dropwise. After stirring at room temperature for 20 minutes, the reaction mixture was 
quenched with ethyl acetate, washed quickly with brine, dried (anhydrous sodium 
sulphate) and concentrated under vacuum. The product was purified by silica-gel flash 
chromatography, eluting with anhydrous hexane: anhydrous diethyl ether (1:1) primed 
with 1% tricihylamine. 
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Yield 0.46g (34%). Rf 0.42 (system B). FAB mass spectrum: ni/z 684 (Mt). 
'H-NMR (CDC13): ö 1.14-1.42 (m, 12H, 4CH3 i-Pr); 1.88-2.11 (m, 4H, 2, 2' CH2); 
2.67-2.80 (ni, 6H, CH2CN, 3, 3' CH2); 2.94-3.01 (m, 2H, 2CH i-Pr); 3.13-3.19 (t, 
2H, 1 CH2, J=5.9Hz); 3.45-3.59 (m, 2H, CH20); 3.76-3.82 (m, 8H, 1 CH2, 20CH3); 
6.78-6.84,7.15-7.45 (m, 13H, AM). 31P-NMR (CDC13): 8 149.69 (s). 
1-(4,4'-Dimethoxytrityloxy)dithiodi propan- V-0- 	[33] 
DMTrO SS OTOSy1 
To a solution of compound [31] (leq., 9.57rnmol, 4.64g) in anhydrous pyridine 
(60ml) cooled to 0°C was added p-toluenesulphonyl chloride (1.2eq., 11.48mmol, 
2.19g). After stirring for 30 minutes at 0°C and a further 16 hours at 200C, the 
solution was evaporated to an oil which was coevaporated twice with toluene. The 
residue ws taken up in dichloromethane (SOml) and washed successively with water 
(30ml) and brine (3 x 30m1). The organic layer was dried (anhydrous sodium 
sulphate) and the solvent removed under vacuum. The product was purified by silica-
gel flash chromatography eluting with methanol in dichloromethane (0-2%) primed 
with 1% triethylamine. 
Yield 2.88g (47%). Rf 0.78 (system E). )max(1T1lm)Icm' 3056 (m), 2930 (s), 
2835 (m), 1606 (s), 1581 (m), 1508 (s), 1361 (s), 1299 (m), 1249 (s), 1176 (s), 1033 
(s), 986 (m). 919 (s), 827 (s), 736 (s), 663 (s). FAB mass spectrum: m/z 638.1851 
[calc. for C31H3806S7 (Mt): 638.1830]. 1 H-NMR (CDC13): 1.87-2.07 (m, 4H, 2, 
2' CH2); 2.43 s, 3H, Ar-CH3); 2.58-2.78 (m, 4H, 3, 3' CH2); 3.10-3.16 (t, 2H, 1 
CH2, J=6.lHz); 3.68-3.75 (t, 2H, 1' CH7, J=6.lHz); 3.78 (s, 6H, 20CH3); 6.78-6.84, 
7.13-7.44, 7.75-7.80 (rn, 17H, ArH). 13C-NMR (CDC13): 8 21.51 (ArCH3); 27.98 
(CH2); 29.54 (CH2); 33.66 (CH2S); 35.49 (CH2S); 55.05 (20CH3); 60.73 (CH20); 
61.37 (CH20); 85.66 (C); 112.84 (2ArCH); 112.94 (2ArCH); 126.52 (ArCH); 127.59 
127 
(2ArCH); 127.73 (2ArCH); 127.93 (2ArCH); 128,95 (2ArCH); 129.79 (4ArCH); 
132.57 (ArC); 136.14 (2ArC); 139.27 (ArC); 144.93 (ArC); 158.18 (2ArC). 
N-PhthaIoyI-1'-amino-1-(4,4'-dimethoxytrityoxy)dithiodiprOPafle [34] 
DMTrO 	S - S 	 N 
To a solution of compound [33] (leq., 1.36mrnol, 0.86g) in anhydrous N,N-
dimethylformaniide (20m1) was added potassium phthalimide (1.1eq., 1.56mmol, 
0.29g). The reaction mixture was stirred for 2 hours at 550C at which point it was 
diluted with dichioromethane (20m1) and washed with water (3 x 30m1). The organic 
layer was dried (anhydrous sodium sulphate) and concentrated under vacuum. The 
residue was purified by silica-gel flash chromatography, eluting with methanol in 
dichioromethane (0-2%) primed with 1% triethylamine. 
Yield 0.74g (86%). Rf 0.67 (system E). l3max(fllm)/cm'  3055 (m), 2930 (s), 
2835 (m), 1771 (m, CO), 1713 (s, CO), 1676 (s, CO), 1607 (s), 1580 (w), 1508 (s), 
1394 (s), 1365 (w), 1300 (m), 1249 (s), 1176 (s), 1154 (w), 1086 (s), 1033 (s), 1011 
(w), 902 (w), 829 (s), 754 (w), 721 (s), 658 (w). FAB mass spectrum: nz1z 613.1969 
[caic. for C35H35N05S2 (Mt): 613.19571. 1H-NMR (CDC13): 6 1.91-2.11 (m, 4H, 
2, 2' CH2); 2.62-2.70 (t, 2H, 3 CH?, 1=7.1Hz); 2.75-2.82 (t, 2H, 3' CH2, J=7.1Hz); 
3.10-3.16 (t, IH, 1 CH2, J=6.lHz); 3.72-3.78 (m, 8H, 20CH3, 1 CH2); 6.77-6.82, 
7.16-7.43. 7.65-7.83 (m, 17H, ArH). 13C-NMR (CDC13): 6 27.94 (CH2); 29.60 
(CH2); 35.64 (CH2S); 35.73 (CH-S): 36.58 (CH2N); 54.98 (20CH3); 61.43 
(CH20); 85.61 (C); 112.79 (4ArCH); 123.05 (2ArCH); 126.44 (ArCH); 127.53 
128 
(2ArCH); 127.92 (2ArCH); 129.78 (4ArCH); 131.80 (2ArC); 133.79 (2ArCH); 
136.17 (2ArC); 144.94 (ArC); 158.12 (2ArC); 168.10 (2C0). 
1'-Amino-1.(4,4'-dimethoxytrityloxy)dithiodipropane [351 
DMTrO SS NH2 
To a solution of compound [34] (leq., 3.21mmol, 1.97g) in 
dichioromethane/methanol (1:1, 15m1) was added hydrazine hydrate (1.leq., 
3.53mmol, 0.18g, 0.17m1). The mixture was stirred for 22 hours at room temperature 
then concentrated under vacuum. The residue was dissolved in dichioromethane 
(40m1) and washed with 2M sodium hydroxide solution (30m1). The aqueous phase 
was extracted with diethyl ether (3 x 30m1) and the combined organic layers were 
dried (anhydrous sodium sulphate) and concentrated under vacuum. The residue was 
purified by silica-gel flash chromatography, eluting with dichloromethane:methanol 
(9:1) primed with 1% triethylamine. 
Yield 0.87g (56%). Rf 0.18 (system D). 0max(film)/cm 1  3412 (m, NH), 3374 
(rn, NH), 2929 (s), 2834 (m), 1607 (s), 1580 (w), 1508 (s), 1299 (m), 1249 (s), 1175 
(s), 1033 (s), 827 (s). FAB mass spectrum: mlz 485.2069 [calc. for C27H35NO3S2 
(M + 2): 485.2058]. 'H-NMR (CDC13): 6 1.74-1.82 (t, 2H, 2 CH2, J=6.6Hz); 1.93-
2.00 (t, 2H, 2' CH2, J=6.6Hz); 2.66-2.83 (m, 6H, 1', 3, 3' CH2); 3.11-3.17 (t, 2H, 1 
CH2, J=6.lHz); 3.77 (s, 6H, 20CH3); 6.78-6.83, 7.14-7.43 (m, 13H, ArH). 13C-
NMR (CDC13): 8 29.62 (CH2); 32.71 (CH2); 35.67 (CH2S); 36.04 (CH2S); 40.55 
(CH2N); 55.01 (20CH3); 61.49 (CH2O); 85.64 (C); 112.81 (4ArCH); 126.48 
(ArCH); 127.t7 (2ArCH); 127.93 (2ArCH); 129.81 (4ArCH); 136.18 (2ArC); 144.96 




nC16H33O 	 0 
flCH 	O S -s 	ODMTr 16 33O
)
~   
Compound [35] (leq., 0.23g, 0.47mmol) was coevaporated twice with 
anhydrous dichioromethane then dissolved in anhydrous dichioromethane (lOmi) to 
which was added compound [27] (leq., 0.47mmol, 0.33g) and anhydrous 
triethylamine (leq., 0.471nmol, 0.048g, 0.066rn1). After stirring at room temperature 
for 20 hours, dichlorornethane was added (20m1) and the resulting solution washed 
with 0.5M sodium hydrogen carbonate solution (20ml), brine (3 x 20m1) and water 
(20m1). The organic layer was dried (anhydrous sodium sulphate), concentrated under 
vacuum, then the product was purified by silica-gel flash chromatography, eluting with 
hexane:erhyl acetate (1:1) primed with 1% triethylamine. 
Yield 0.41g (82%). Rf 0.53 (system B). umax(filrn)/crn 3391 (w, NH), 2922 
(s), 2851 (s), 1740 (s, CO), 1607 (s), 1508 (s), 1463 (s), 1372 (s), 1299 (w), 1245 (s), 
1175 (m), 1114 (m), 1043 (s), 827 (m), 791 (w). FAB mass spectrum: m!z 1049.7242 
[calc. for C63H103N07S7 (Mt): 1049.71761. 'H-NMR (CDC13): 5 0.84-0.87 (t, 
6H, 2CH3 C16,J=6.5Hz); 1.25 (s, 60H, 30CH2); 1.86-1.96 (m, 4H, 2,2' CH2); 2.61-
2.79 (m, 4H, 3, 3' CH2); 3.15 (m, 2H, I CH,)); 3.39-3.54 (m, 7H, 1 CH2, 5H C35); 




nC1 6H33O 3, ON 	 S - S 	 OH 
Compound [36] (0.34g, 0.32mmol) was dissolved in trichloroacetic acid (5% in 
dichioromethane, 5m1) and stirred at room temperature for 16 hours. The reaction 
mixture was diluted with dichiorornethane (20m1), washed with 0.5M sodium 
hydrogen carbonate solution until the organic layer became neutral (x5) and dried 
(anhydrous sodium sulphate). The solvent was removed under vacuum and the 
product was purified by silica-gel flash chromatography, eluting with hexane:ethyl 
acetate (1:1) to give a white solid. 
Yield 0.090g (38%). Rf 0.50 (system Q. MP 45470C. Dmax(film)/cm' 3315 
(s, OH), 3013 (w), 2959 (s), 2917 (s), 2849 (s), 1680 (s, CO), 1607 (m), 1540 (m), 
1468 (s), 1454 (s), 1375 (m), 1260 (s), 1095 (s), 1017 (s), 875 (w), 805 (s). FAB 
mass spectrum: nl/z 748.59473 [calc. for C42H86N05S2 (M + 1): 748.59471]. 'H-
NMR (CDCI3): 6 0.85-0.88 (t, 6H, 2CH3 C16, .1=6.7Hz); 1.24 (s, 60H, 30CH2); 
1.86-1.98 (m, 4H, 2, 2' CH2),  2.69-2.73 (t, 2H, 3' CH2, J=7.lHz); 2.79-2.83 (t, 2H, 3 
CH2, J=7.lHz); 3.25-3.47 (nn, 7H, 1' CH2, 5H C35); 3.73-3.76 (t, 2H, 1 CH2, 
J=6.OHz). Analysis: 67.75% C, 11.63% H, 2.06% N (caic. for C42H85N05S2: 




DMTrO 	S - S 	N 
Compound [35] (leq., 1.03mmol, 0.50g) was coevaporated twice with 
anhydrous dichioromethane then dissolved in anhydrous dichloromethane (1 Dm1). To 
this was added cholesteryl chioroformate [1] (leq., 1.03mmol, 0.46g) and anhydrous 
triethylamine (leq., 1.03mml, 0.10g, 0.14iiil). After stirring at room temperature for 
24 hours, the reaction mixture was diluted with dichioromethane (20m1) then washed 
with 0.5M sodium hydrogen carbonate solution (20m1), brine (3 x 20m1) and water 
(20m1). The organic layer was dried (anhydrous sodium sulphate), the solvent 
removed under vacuum and the product purified by silica-gel flash chromatography, 
eluting with hexane:diethyl ether (1: 1) primed with 1% triethylamine. 
Yield 0.80g (87%). Rf 0.34 (system B). Dmax(film)/cm' 3365 (w, NH), 2952 
(s), 2926 (s), 2852 (s), 1703 (s, CO), 1607 (s), 1508 (s), 1463 (s), 1378 (m), 1299 
(m), 1249 (s), 1176 (s), 1082 (m), 1037 (s), 1012 (m), 902 (w), 828 (s), 701 (m). 
FAB mass spectrum: m/z 895.52426 [calc. for C55H7705NS2 (Mt): 895.52428]. 
'H-NMR (CDC13): 8 0.67-1.60 (m, 45H, all signals cholesterol moiety); 1.82-2.03 (m, 
411, 2, 2' CH2); 2.62-2.69 (t, 2H, 3' CH2, .1=7.1Hz); 2.76-2.83 (t, 2H, 3 CH2, 
J=7.lHz); 3.12-3.26 (m, 4H, 1, 1' CH-)), 3.79 (s, 6H, 20CH3); 6.80-6.84, 7.15-7.45 
(m, 13H, AM). 
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1'-(Cholesteryl-3-carbonylamino)dithiodipropan-1-oI [39] 
Compound [38] (0.74g, 0.83mmol) was dissolved in trichioroacetic acid (5% in 
dichioromethane, 10m1) and stirred at room temperature for 16 hours. The reaction 
mixture was diluted with dichioromethane (20m1), washed with sodium hydrogen 
carbonate solution until the organic layer became neutral (0) then dried over 
anhydrous sodium sulphate. After the solvent was removed under vacuum, the 
product required no further purification. 
Yield 0.39g (79%). Rf 0.44 (system Q. Umax(film)/cm' 3349 (s, OH), 2929 
(s), 2849 (s). 1693 (s, CO), 1530 (s), 1466 (s), 1439 (s), 1252 (s), 1134 (m), 1044 (s), 
1015 (m), 84() (w). FAB mass spectrum: m/z 594.40143 [caic. for C34H60NO3S2 
(M + 1): 594.401441. 'H-NMR (CDCI3): ö 0.67-1.59 (m, 45H, all signals 
cholesterol moiety); 1.76-1.98 (m, 4H, 2, 2' CH2); 2.69-2.72 (t, 2H, 3' CH2, 
J=7.lHz); 2.7-2.81 (t, 2H, 3 CH2, ./=7.1Hz); 3.21-3.28 (m, 2H, 1' CH2); 3.61-3.70 





DMTrO 	 S - S 	 O_P_ 0
-b  
0 NHEt3 
Compound [31] (leq., 0.98g, 2.02mmol) was coevaporated twice with 
anhydrous pyridine then dissolved in anhydrous tetrahydrofuran (30m1). This was 
added to a solution of 2-chiorophenyldichiorophosphate (1.5eq., 3.03mmol, 0.74g, 
0.49m1) and anhydrous triethylamine (3eq., 6.06rnmol, 0.61g, 0.84m1) in anhydrous 
tetrahydrofuran (30m1). After stirring for 2 hours at room temperature, the reaction 
was quenched with aqueous 1.OM triethylammonium bicarbonate (30m1) and left 
stirring for a further 2 hours. Dichioromethane (30m1) was added and the organic 
layer was washed again with aqueous l.OM triethylammonium bicarbonate (2 x 30m1), 
water (30m1) then dried (anhydrous sodium sulphate). The solvent was removed by 
evaporation and the product purified by silica-gel flash chromatography, eluting with 
methanol in dichioromethane (0-5%) + 1% triethylamine to give a yellow oil. 
Yield 1.34g (85%). Rf 0.37 (system F). Dm (film)/cm 3451 (s, OH), 3392 
(s, OH), 2953 (s), 2927 (s), 2835 (s), 2674 (s), 2489 (s), 1607 (s), 1585 (m), 1505 (s), 
1444 (m), 1392 (w), 1298 (m), 1247 (s), 1176 (s), 1092 (s), 1032 (s), 949 (m), 903 
(s), 828 (s), 756 (s). FAB mass spectrum: mlz 675.14028 [calc. for C33H33C107PS2 
(Mt): 675.14069]. 'H-NMR (CDC13): 6 1.09-1.16 (t, 9H, 3CH3 Eth, J=7.3Hz); 
1.87-1.97 (m, 4H, 2, 2' CH2); 2.63-2.80 (in, IOH, 3, 3' CH, 3CH2 Eth); 3.07-3.13 (t, 
2H, 1 CH2, .1=6.0Hz); 3.73 (s, 6H, 20CH3); 4.02-4.08 (m, 2H, 1' CH2); 6.75-7.42 
(m, 16H, ArH); 7.61-7.66 (dd, 1H, 5 CH chiorophenyl, J5..6=1.3Hz, J45=8.2Hz). 
13CNMR (CDC13): 6 9.70 (3CH3); 29.55 (CH2); 30.09 (CH2); 34.79 (CH2S); 35.54 





112.77 (4ArCH); 121.10 (ArCH); 123.16 (ArCH); 124.69 (ArC); 126.41 (ArCH); 
127.29 (ArCH); 127.50 (2ArCH); 127.89 (2ArCH); 129.60 (ArCH); 129.75 (4ArCH); 
136.16 (2ArC); 144.92 (ArC); 149.22 (ArC); 158.10 (2ArC). 31P-NMR (CDC13): 
-4.49(s). 
Triethylammoni um[cholesteryl-3-(2-chlorophenylphoSphate)] [42] 
Cholesterol (leq., 0.39g, l.00mmol) was coevaporated with anhydrous pyridine 
then dissolved in anhydrous tetrahydrofuran (I 5m1). This was added to a solution of 
2-chiorophenyldichlorophosphate (1 .5eq., 1.50mmol, 0.37g, 0.24m1) and anhydrous 
triethylamine (3eq., 3.00mrnol, 0.30g, 0.42m1) in anhydrous tetrahydrofuran (15m1). 
After stirring at room temperature for 24 hours, the reaction was quenched with 
aqueous 1 .OM triethylammonium bicarbonate (20ml) and allowed to stir for a further 2 
hours. Dichlorornethane (20ml) was added and the organic layer was washed again 
with aqueous 1 .OM tnethylamrnonium bicarbonate (20m1) and water (20m1). After 
drying over anhydrous sodium sulphate and removal of the solvent under vacuum, the 
product was purified by silica-gel flash chromatography, eluting with methanol in 
dichloromethane (0-5%) + 1% triethylanilne to give a white solid. 
Yield 0.46g (68%). Rf 0.42 (system F). MP 215-2180C. 	(nujol)/cm' 
3451 (s, OH), 2954 (s), 2923 (s), 2853 (s), 2620 (m), 2369 (m), 1585 (s), 1479 (s), 
1280 (m). 1244 (s), 1094 (s), 1033 (s), 1024 (m), 899 (s), 888 (s), 846 (w), 767 (m), 
739 (m), 677 (m). FAB mass spectrum: m/z 575 (Mt). 'H-NMR (CDC13): ö 0.61- 
135 
1.57 (m, 54H, 3CH3 Eth, all other signals cholesterol moiety); 2.89-3.00 (q, 6H, 
3CH2 Eth, J=7.3Hz); 6.83-7.70 (m, 4H, ArH). 13C-NMR (CDC13): 8 8.52 (3CH3); 
11.63 (CH3); 18.49 (CH3); 19.14 (CH3); 20.81 (CH2); 22.36 (CH3); 23.61 (CH2); 
24.07 (CH2); 27.78 (CH); 28.03 (CH2) 29.61 (CH2); 31.65 (CH2, CH); 35.58 (CH); 
35.95 (CH')); 36.23 (C); 36.92 (CH2); 39.28 (CH2); 39.52 (CH2); 39.98 (CH2); 
42.06 (C); 45.29 (3CH2N); 49.78 (CH); 55.9() (CH); 56.48 (CH); 75.83 (CH); 121.09 
(ArCH); 121.56 (CH); 122.77 (ArCH); 124.42 (ArC); 127.22 (ArCH); 129.46 
(ArCH); 140.39 (C); 149.46 (ArC). 31P-NMR (CDC13): 6 -5.12 (s). Analysis: 
69.22% C, 9.50% H, 2.11% N (caic. for C39H65C1N04P: 69.05% C, 9.66% H, 
2.06% N). 




1 	 'J~ 
0 -O(CH2)6N 0 
0 Et3NH 
1-(Cholesteryl-3-carbonylarnino)hexan-6-o1104 (1 eq., 1.65g. 3.1 immol) was 
coevaporated twice with anhydrous pyridine then dissolved in anhydrous 
tetrahydrofuran (30ml) to which was added 2-chiorophenyldichiorophosphate (1.5eq., 
4.67mmol, 1.14g, 0.76m1) and anhydrous triethylamine (3eq., 9.33mmol, 0.94g, 
1.30m1). After stirring for 5 hours at room temperature, the reaction was quenched 
with aqueous I .OM triethylammonium bicarbonate (20m1) and left stirring for another 
2 hours. Dichioromethane (30m1) was added and the organic layer was washed again 
with aqueous 1.OM triethylammonium bicarbonate (30m1) then water (30m1). The 
136 
solution was dried (anhydrous sodium sulphate), the solvent removed by evaporation 
and the product purified by silica-gel flash chromatography, eluting with methanol in 
dichioromethane (0-5%) + 1% triethylamine to give a white solid. 
Yield 1.45g (57%). Rf 0.34 (system F). NIP 198-2000C. u(nujo1)/cm 1  
3362 (m), 2951 (s), 2922 (s), 2851 (s), 2675 (m), 2534 (m), 2337 (m), 1711 (s, CO), 
1586 (m), 1242 (s), 1091 (s), 1016 (m), 905 (s), 672 (w). FAB mass spectrum: m/z 
720 (Mt). 1H-NMR (CDC13): ö 0.61-1.58 (m, 62H, 3CH3 Eth, 4CH2, all other 
signals cholesterol moiety); 2.93-3.04 (m, 8H, 3CH2 Eth, CH2N); 3.88-3.97 (m, 2H, 
CH20); 6.84-7.29 (m, 3H, AM); 7.59-7.64 (dd, 111, 5 CH chlorophenyl, J56=1.2Hz, 
J45=8.2Hz). 13CNMR (CDC13):  6 8.28 (3CH3); 11.60 (CH3); 18.46 (CH3); 19.09 
(CH3); 20.77 (CH2); 22.32 (CH3); 22.59 (CH3); 23.56 (CH2); 24.02 (CH2); 25.07 
(CH2); 26.06 (CH2); 27.74 (CH); 27.96 (CH2); 29.64 (CH2); 30.12 (CH2); 30.27 
(CH2); 31.61 (CH, CH2); 35.53 (CH); 35.91 (CH2); 36.28 (C); 36.74 (CH2); 38.33 
(CH2); 39.25 (CH2); 39.46 (CH); 40.50 (CH,)); 42.03 (C); 45.26 (3CH2N); 49.72 
(CH); 55.84 (CH); 56.41 (CH); 65.85 (CH2); 73.77 (CH); 121.06 (ArCH); 122.09 
(CH); 122.95 (ArCH); 124.47 (ArC); 127.20 (ArCH); 129.50 (ArCH); 139.65 (C); 
149.25 (ArC); 155.93 (CO). 31P-NMR (CDC13): ö -4.60 (s). Analysis: 67.59% C, 
9.48% H, 3.30% N (calc. for C46H78C1N206P: 67.25% C, 9.57% H, 3.41% N). 
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1-(4,4'-Dimethoxytrityloxy)dithiodipropan-1 '-0-[(2,5-dichlorophenyl)-1- 
benzotriazoyl-6-trifl uoromethyl]phosphorothioate [45] 
S 
DMTrO 	 S - S 	 p P 0 N N 
F3  C 
Cl 
Compound [31] (leq., 1.0g. 2.O6mmol) was coevaporated twice with anhydrous 
pyridine and a solution of 2,5-dichloropheny! -O,O-his[(6-trifluoromethyl)- 1-
benzotriazoyl]phosphorothioate74  (1.5eq., 3.09mmol, 0.2M, 15.47m1) in anhydrous 
dioxane was added. The mixture was stirred at room temperature for 20 minutes then 
diluted with dichioromethane (15m1) and washed with brine (2 x 20m1). The organic 
layer was dried (anhydrous sodium sulphate), then the product was purified by silica-
gel flash chromatography, eluting with ethyl acetate in dichloromethane (0-50%) to 
give a clear oil.. 
Yield 1.22g (65%). Rf 0.39 (system F). umax(filrn)Icm  3408 (s, OH), 3067 
(w), 2986 (s), 2852 (s), 2685 (s), 2504 (s), 1580 (s), 1474 (s), 1392 (s), 1363 (w), 
1251 (m), 1232 (m), 1169 (s), 1126 (s), 1092 (m), 1037 (ni), 937 (s), 872 (m), 804 
(s), 746 (m). FAB mass spectrum: m/z 910 (Mt). 'H-NMR (CDC13): ö 1.92-2.02 
(m, 4H, 2, 2' CH2); 2.53-2.75 (m, 4H, 3, 3' CH2); 3.59-3.66 (m, 2H, 1 CH2); 3.76 (s, 
6H, 20CH3); 4.15-4.18 (m, 2H, 1' CH')); 6.77-8.07 (m, 19H, ArH). 13C-NMR 
(CDC13): ö 28.29 (CH2); 30.11 (CH-)); 34.70 (CH2S); 36.93 (CH2S); 54.94 
(20CH3); 60.99 (CF3); 65.13 (CH20): 65.25 (CH7O); 112.74 (4ArCH); 120.76 
(ArCH); 121.93 (ArCH); 122.76 (ArCH); 123.73 (ArCH); 125.07 ArCH); 126.25 
(ArC); 127.48 (ArCH); 128.86 (2ArCH); 129.67 (2ArCH); 130.24 (ArCH); 130.41 
(4ArCH); 131.90 (2ArC); 132.36 (2ArC); 139.35 (ArC); 143.87 (ArC); 148.61 (ArC); 
148.97 (ArC); 158.18 (2ArC). 31P-NMR (CDC13):  5 53.04 (s); 55.03 (s). 
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OEt3NH 
Dithiodiethyl- 1 -(4,4'-dimethoxytrityl)- 101126  [8] (ft 80g, 1 .75mmol) was 
coevaporated twice with anhydrous pyridine then dissolved in anhydrous 
tetrahydrofuran (30m1). 	This was added to a solution of 2- 
chloropheny1dichlorophosphate (1. Seq.. 2. ô3mmol, 0.64g, 0.43ml) and anhydrous 
niethylamine (3eq., 5.25mmol, 0.53g, 0.73m1) in anhydrous tetrahydrofuran (20m1). 
After stirring at room temperature for 2 hours, the reaction mixture was quenched 
with aqueous 1.OM triethylammonium bicarbonate (30m1) and stirred for a further 2 
hours at room temperature. Dichiorornethane (20m1) was added and the organic layer 
washed again with aqueous 1.OM triethylammonium bicarbonate (2 x 20m1) and water 
(20m1). Following drying (anhydrous sodium sulphate) and removal of the solvent 
under vacuum, the product was purified by silica-gel flash chromatography, eluting 
with methanol in dichloromethane (0-5%) + 1 % triethylamine to give a clear oil. 
Yield 0.94g (71%). Rf 0.28 (system F). uniax(film)/cm' 3403 (s, OH), 3060 
(m), 2932 (s), 2835 (m), 2671 (rn), 2483 (s), 2288 (m), 1607 (s), 1585 (m), 1508 (s), 
1479 (s), 1445 (m), 1396 (w), 1298 (w), 1248 (s), 1176 (s), 1091 (s), 1061 (s), 1031 
(s), 901 (s), 831 (s), 757 (s), 702 (rn). FAB mass spectrum: m/z 646. 10157 [caic. for 
C31H3207PS7C1 (Mt): 646.101551. 1 H-NMR (CDC13): 6 1.12-1.28 (t, 9H, 3CH3 
Eth, J=7.3Hz); 2.77-2.86 (m, 1OH, 2, 2' CH7, 3CH7 Eth); 3.27-3.32 (m, 4H, 1, 1' 
C112); 3.73 (s, 6H, 20CH3); 6.75-7.42 (m, 16H, ArH); 7.59-7.63 (dd, 1H, 5 CH 
chlorophenvl, J56=1.2Hz, J45=8.2Hz). 13C-NMR (CDC13): 9.13 (3CH3); 38.99 
(CH2S); 39.33 (CH2S); 45.50 (3CH-)N): 54.95 (20CH3); 61.74 (CH20); 64.02 
119 
(CH20); 85.91 (C); 112.81 (4ArCH); 121.26 (ArCH); 123.14 (ArCH); 124.69 (ArC); 
126.46 (ArCH); 127.24 (ArCH); 127.52 (2ArCH); 127.88 (2ArCH); 129.52 (ArCH); 
129.75 (4ArCH); 135.87 (2ArCH); 144.64 (ArC); 149.09 (ArC); 158.15 (2ArC). 
31P-NMR (CDC13): 8 -5.25 (s). 
1-(tButyIdirnethyIsiIyIOxy)dithiOdiPrOPan-l'-Ol [47] 
TBDMSO S-SOH 
Compound [30] (leq., 3.10g. 17.00mmol) was coevaporated twice with 
anhydrous pyridine then dissolved in anhydrous pyridine (25ml) to which was added t-
butyldimethylsilyl chloride (leq., 17.00mmol, 2.56g). The reaction mixture was 
stirred for 20 hours at room temperature at which point the solvent was removed by 
evaporation. The residue was dissolved in dichioromethane (25m1) and washed with 
brine (2 x 15m1). After drying over anhydrous sodium sulphate and concentration by 
evaporation, the product was purified by silica-gel flash chromatography, eluting with 
dichlorometha.ie to give a clear liquid. 
Yield 3.06g (61%). Rf 0.37 (system E). umax(fu1m)Icm 3364 (s, OH), 2953 
(s), 2929 (s), 2866 (s), 1469 (s), 1386 (m), 1360 (w), 1254 (s), 1214 (w), 1154 (w), 
1100 (s), 1059 (m), 1007 (w), 947 (s), 835 (s), 776 (s), 717 (w), 663 (m). FAB mass 
spectrum: m/z 297.13783 [caic. for C12H2902S2Si (M + 2): 297.13782]. 1H-NMR 
(CDC13): 8 0.03 (s, 6H, 2CH3); 0.87 (s, 9H, 3CH3); 1.81-2.00 (m, 4H, 2, 2 CH2); 
2.72-2.81 (m, 4H, 3, 3' CH2); 3.65-3.77 (m, 4H, 1, 1' CH2). 13C-NMR (CDC13): ö 
-5.52 (2CH3Si); 18.08 (C); 25.72 (3CH3); 31.57 (CH2); 31.83 (CH2); 34.82 (CH2S); 
34.92 (CH2S); 60.63 (CH20); 60.99 (CH2O). 
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1.(tButyIdimethytsily1oxy)dithiodiprOpan-1'-O-(p-tO1UefleSUIphonate) [48] 
FBDMSO S_ S OTosyl 
Compound [47] (leq., 1.65g, 5.58mmol) was coevaporated three times with 
anhydrous pyridine then dissolved in anhydrous pyridine. The solution was cooled to 
0°C and p-toluenesulphonyl chloride (1.2eq., 6.70mmol, 1.28g) in anhydrous pyridine 
(20ml) was added. After stirring for 30 minutes at 0°C, then 3 hours at room 
temperature, the reaction mixture was evaporated to an oil which was coevaporated 
twice with toluene. The residue was taken up in dichioromethane (30m1), washed with 
water (20m1) and brine (3 x 20m1) and then dried (anhydrous sodium sulphate). 
Removal of the solvent by evaporation was followed by purification of the product by 
silica-gel flash chromatography, eluting with methanol in dichloromethane (0-5%), to 
give a clear oil. 
Yield I .5g (74%). Rf 0.74 (system E). l)max(fi1rn)/cm 2953 (s), 2928 (s), 
2855 (s), 1594 (s), 1468 (s), 1377 (s), 1254 (s), 1212 (w), 1187 (m), 1174 (s), 1098 
(s), 921 (m), 835 (s), 812 (s), 777 (s), 655 (s). FAB mass spectrum: m!z 452.15453 
[caic. for C19H3604S3Si (M + 2): 452.15449]. 1H-NMR (CDC13): ö 0.02 (s, 6H, 
2CH3); 0.85 (s, 9H, 3CH3); 1.80-2.07 (m, 4H, 2, 2' CH2); 2.44 (s, 3H, ArCH3); 2.59-
2.83 (m, 411, 3, 3' CH2); 3.63-3.78 (m, 4H, 1, 1' Cl-I2); 7.25-7.39 (d, 2H, 2, 6 CH 
tosyl, J23 6 5=8.4Hz); 7.85-7.89 (d, 2H, 3, 5 CH tosyl, J32,56=8.5Hz). 13C.-NIVIR 
(CDC13): 6 -5.55 (2CH3Si); 18.04 (C); 21.58 (CH3); 25.69 (3CH3); 27.93 (CH2); 
31.84 (CH2); 33.54 (CH2S); 34.92 (CH2S); 60.81 (CH20); 60.93 (CH20); 126.75 
(ArCH); 127.S4 (ArCH); 129.71 (ArCH); 130.04 (ArCH); 132.52 (ArC); 146.67 
(ArC). 
14 
N-Phthaloyl- 1 '-amino-i .(t-butyldimethylsilyloxy)dithiodi propane [49] 
0 
TBDMSO 	 S - S 	 N 
0 
To solution of compound [48] (leq., 1.75g, 3.88mmol) in anhydrous N,N-
dimethylformamide (15ml) was added potassium phthalimide (1.leq., 4.27mmol, 
0.79g). The reaction mixture was stirred at 550C for 16 hours, at which point it was 
diluted with dichioromethane (20m1), washed (water, 2 x 20m1) and dried (anhydrous 
sodium sulphate). After removal of the solvent by evaporation, the product was 
purified by silica-gel flash chromatography, eluting with methanol in dichloromethane 
(0-5%) to give a waxy, white solid. 
Yield 1.8g (90%). Rf 0.73 (system E). Umax(film)/cm' 3086 (m), 2951 (s), 
2928 (s), 2854 (s), 1771 (m, CO), 1714 (s, CO), 1678 (s, CO), 1595 (s), 1466 (m), 
1426 (m), 1393 (s), 1360 (s), 1256 (s), 1188 (s), 1008 (m), 947 (w), 836 (s), 777 (s), 
717 (s), 690 (w), 660 (s). 	FAB mass spectrum: mlz 426.15929 [caic. for 
C20H32NO3S7Si (M + 1): 426.15928]. 'H-NMR (CDC13): 6 0.02 (s, 6H, 2CH3); 
0.86 (s, 9H, 3CH3); 1.83-1.90 (m, 2H, 2 CH2); 2.04-2.12 (m, 2H, 2' CH2); 2.65-2.77 
(m, 4H, 3, 3 CH2); 3.63-3.70 (m, 2H, 1 CH2); 3.74-3.80 (m, 211, 1 CH2); 7.67-7.85 
(m, 4H, ArH). 13C-NMR (CDC13): 6 -5.46 (2CH3Si); 18.14 (C); 25.77 (3CH3); 
28.05 (CH2); 31.94 (CH7); 35.12 (CH7S); 35.76 (CH2S); 36.68 (CH2N); 60.98 
(CH20); 123.11 (2ArCI-l); 131.90 (2ArC); 133.83 (2ArCH); 168.14 (2C0). 
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1 '-Amino-1-(t-butyldimethylsilyloxy)dithiodipropane [50] 
TBDMSO S —SNH2 
To a solution of compound [49] (leq., 3.14g, 7.38mmol) in a 
methanol/dichioromethane mixture (1:1, lOmi) was added hydrazine hydrate (1.5eq., 
11.lmmol, 0.55g, 0.54m1). The mixture was stirred at room temperature for 17 hours, 
at which point the solvent was removed by evaporation. The residue was dissolved in 
dichioromethane (20m1), washed with 2M sodium hydroxide solution (20m1) then the 
aqueous phase extracted with diethyl ether (3 x 20m1). After drying (anhydrous 
sodium sulphate) and removal of the solvent by evaporation, the residue was purified 
by silica-gel flash chromatography, eluting with methanol in dichloromethane (0-10%). 
Yield 1.32g (61%). Rf 0.12 (system D). 	max(film)/cm 3443 (m, NH2), 
3288 (m, NH2), 2952 (s), 2927 (s), 2855 (s), 1649 (m), 1469 (s), 1254 (s), 1176 (w), 
1099 (s), 1009 (w), 947 (m), 835 (s), 776 (s). FAB mass spectrum: m/z 296.15401 
[caic. for C12H30NO2S2Si (Mt): 296.153811. 1H-NMR (CDC13): 8 0.03 (s, 6H, 
2CH3); 0.87 (s, 9H, 3CH3); 1.79-1.92 (n], 4H, 2, 2' CH2); 2.68-2.81 (m 6H, 1', 3, 3' 
CH2); 3.64-3.70 (t, 2H, 1 CH2, 1=6.OHz). 13C-NMR (CDC13): 8 -5.48 (2CH3Si); 
18.14 (C); 25.76 (3CH3); 31.95 (CH2); 32.78 (CH2); 35.11 (CH2S); 36.03 (CH2S); 
40.60 (CH, CH2N); 61.02 (CH20). 
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[1 '-(4,4'-Dimethoxytrityl)] biotin-2-nitrophenylester [51] 
0 
DMTr A 





(+)Biotin-2-ninophenyl ester 157  (leq., 0.45g, 1.23mmol) was coevaporated 
twice with anhydrous pyridine then dissolved in anhydrous pyridine (lOmi) to which 
was added 4,4-dimethoxytrityl chloride (1.2eq., 1.48mrnol, 0.50g). After stirring at 
room temperature for 16 hours, reaction was incomplete and a further 0.18g 
(0.53mmol) of 4,4-dimethoxytrityl chloride were added. The reaction mixture stirred 
for a further 6 hours at which point all the starting material (Rf 0.21, system E) had 
reacted. The solvent was removed by evaporation, the residue dissolved in 
dichioromethane (25m1) and washed with water (20rn1) and brine (2 x 20m1). After 
drying (anhydrous sodium sulphate) and concentration under vacuum, the product was 
purified by silica-gel flash chromatography, eluting with methanol in dichloromethane 
(0-5%) primed with 1% uiethylamine. 
Yield 0.67g (81%). Rf 0.42 (system E). MP 69-71°C. u(nujo1)/cm 3304 
(w, NH), 2934 (s), 2837 (s), 1700 (s. CO), 1605 (m), 1531 (s), 1508 (s), 1349 (m), 
1298 (w), 1252 (s), 1182 (m), 1112 (w), 1034 (m), 649 (m). FAB mass spectrum: 
m/z 667.23508 [calc. for C37H37N307S (Mt): 667.23522]. 'H-NMR (CDC13): 
1.41-1.74 (in, 6H, 6, 7, 8 CH2); 2.18-2.42 (m, 4H, 2, 9 CH2); 3.07-3.09 (m, 1H, 5 
CH); 3.76 (s, 6H, 20CH3); 4.27-4.36 (m, 2H, 3, 4 CH); 6.76-7.68 (m, 16H, AM); 
8.04-8.08 (dd, 1H, 5 CH nitrophenyl, J5.6=1.6Hz, J45=8.lHz). 	13C-NMR 
(CDC13): 8 23.93 (CH2); 27.83 (CH-)); 28.38 (CH2); 33.42 (CH2); 38.88 (CH2S); 
53.94 (CHS); 55.02 (20CH3); 59.53 (CHN); 65.22 (CHN); 72.48 (C); 112.61 
(4ArCH); 123.53 (ArCH); 125.09 (ArCH); 125.54 (ArCH); 126.36 (ArCH); 126.66 
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(ArCH); 127.33 (2ArCH); 129.55 (2ArCH); 131.13 (4ArCH); 135.74 (2ArC); 141.61 
(ArC); 143.64 (ArC); 149.62 (ArC): 158.17 (2ArC); 161.43 (CO); 170.93 (CO). 
Analysis: 66.78% C, 5.51% H, 5.81% N (caic, for C37H37N307S: 66.55% C, 5.58% 
H, 6.29% N). 
1'-[ 1 '_(4,4'.Dirnethoxytrityl)biotinyl]aminO-1-(t- 
butyldimethylsilyloxy)dithiOdiPrOPafle [52] 
0 	 I 
N -  S 	OTBDMS tt 
DMTrN NH 	 I 
0 
Compound [51] (Ieq., 0.62g, 0.85mmol) was dissolved in anhydrous N,N-
dimethylfommmide (8m1) to which was added compound [50] (1.1eq., 0.93mmol, 
0.25g) and anLydrous triethylamine (l.Seq., 1.28mrnol, 0.13g, 0.18m1). After stirring 
at room temperature for 5 days, the solvent was removed by evaporation and the 
residue coevaporated twice with toluene and ethanol. The residue was dissolved in 
dichloromethane (25m1), washed with brine (2 x 20m1) and dried (anhydrous sodium 
sulphate). After removal of the solvent under vacuum, the product was purifed by 
silica-gel flash chromatography, eluting with methanol in dichloromethane (0-5%) 
primed with 1% triethylarnine, to give a yellow solid. 
Yield 0.42g (60%). Rf 0.29 (system E). MP 79-810C. D(nujo1)/cm 3306 
(m, NH), 3062 (rn), 2950 (s), 2930 (s), 2855 (s), 1696 (s, CO), 1606 (m), 1542 (w), 
1506 (s), 1419 (s), 1296 (m), 1263 (s), 1218 (w), 1181 (s), 1097 (m), 1034 (s), 945 
(w), 833 (rn). FAB mass spectrum: m/z 823.35546 [calc. for C43H61N305S3Si 
(Mt): 823.35427]. 1H-NMR (CDCI3): 0.04 (s, 6H, 2CH3); 0.87 (s, 9H, 3CH3); 
1.45-1.55 (m, 4H, biotin 7, 8 Cl-I-)); 1.84-1.91 (m, 6H, 2, 2', biotin 6 CH2); 2.63-2.74 
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(m, 8H, 3, 3', biotin 2, 9 CH2); 3.65-3.70 (rn, 4H, 1, 1' CH2); 3.77 (s, 6H, 20CH3); 
6.77-6.81, 7.11-7.29 (m, 13H, ArH). 13C-NMR (CDC13): ö -5.43 (2CH3Si); 18.14 
(C); 25.00 (CH2); 25.78 (3CH3); 27.78 (CH2); 28.11 (CH2); 28.93 (CH2); 31.95 
(CH2); 35.06 (CH2N); 35.43 (CH2); 35.92 (CH2S); 37.94 (CH2); 39.14 (CH2S); 
54.24 (CHS); 55.10 (20CH3); 59.44 (CHN); 61.02 (CH20); 65.28 (CHN); 72.56 
(C); 112.67 (4ArCH); 126.77 (ArCH): 127.40 (2ArCH); 129.57 (2ArCH); 131.13 
(4ArCH); 135.55 (ArC); 135.63 (ArC); 143.58 (ArC); 158.24 (2ArC); 161.48 (CO); 
172.82 (CO). Analysis: 63.01% C, 7.40% H, 4.73% N (caic. for C43H61N305S3Si: 
62.66% C, 7.46% H, 5.10% N). 
1 '-[1 '(4,4'Dimethoxytrityl)biotinyI]arninodithiodipropafl-1-OI [53] 





- S 	OH 
S \/\//~y 
0 _ 
Compound [52] (0.35g, 0.42mmol) was dissolved in tetrabutylammonium 
fluoride in tetrahydrofuran (1.OM, 5m1) and stirred at room temperature for 16 hours 
at which point all the starting material (Rf 0.75, system D) had reacted. The solvent 
was removed by evaporation and the residue was coevaporated with toluene and then 
dissolved in dichioromethane (20m1). The organic layer was washed with water (2 x 1-1 
lOmi), dried (anhydrous sodium sulphate) and the solvent removed by evaporation. 
The product was purified by silica-gel flash chromatography, eluting with methanol in 
dichloromethane (0-5%) primed with 1% triethylamine. 
Yield 0.26g (87%). Rf 0.68 (system D). umax(film)/cm 3323 (s, OH), 3085 
(rn), 2963 (s), 2929 (s), 2835 (m), 1667 (s, CO), 1644 (m), 1607 (m), 1508 (s), 1439 
(s), 1295 (m), 1254 (s), 1191 (m), 1064 (m), 1032 (s), 906 (w), 821 (m), 752 (m). 
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FAB mass spectrum: m/z 709.26521 [calc. for C37H47N305S3 (Mt): 709.267791. 
1H-NMR (CDC13): 6 1.42-1.45 (rn, 4H, biotin 7, 8 CH2); 1.76-1.89 (m, 6H, 2, 2', 
biotin 6 CH2); 2.23-2.51 (m, 4H, biotin 2, 9 Cl-I2); 2.61-2.66 (t, 2H, 3 CH2, 
J=7.lHz); 2.71-2.76 (t, 2H, 3 CH2, .1=7.1Hz); 3.17 (m, 1H, biotin 5 CH); 3.57-3.64 
(m, 4H, 1, 1 CH2); 3.74 (s, 6H, 20CH3); 4.22 (m, 2H, biotin 3, 4 CH); 6.74-6.77, 
7.06-7.25 (rn, 13H, AM). 13C-NMR (CDC13): 6 25.00 (CH2); 27.60 (CH2); 27.86 
(CH2); 28.70 (CH2); 31.84 (CH2); 35.05 (CH2); 35.21 (CH2N); 36.09 (CH2S); 
37.73 (CH-)S); 39.10 (CH7S); 54.41 (CHS); 55.02 (20CH3); 59.39 (CHN); 60.21 
(CH20); 65.10 (CHN); 72.43 (C); 112.55 (4ArCH); 126.68 (ArCH); 127.29 
(2ArCH); 129.44 (2ArCH) 131.03 (4ArCH); 135.44 (ArC); 135.51 (ArC); 143.48 
(ArC); 158.13 (2ArC); 161.69 (CO); 173.29 (CO). 





H 	H tt N /\^S — S 	 P — H 	 11
I O-b 
,N)r 0- 
0 	 Et3NH 
Compound [53] (leq., 0.22g, 0.31mmol) was dissolved in anhydrous 
teuahydrofuran (lOmi) to which was added 2-chiorophenyiphosphate (1.5eq., 
0.46mmol, 110mg, 76pJ) and anhydrous triethylamine (3eq., 0.93mmol, 94mg, 130p1). 
The reaction mixture was stirred for 3 hours at room temperature, quenched with 
aqueous 1.OM triethylammonium bicarbonate (lOmi) and stirred for a further 2 hours 
at room temperature. Dichioromethane (15m1) was added and the organic layer was 
washed again with aqueous l.OM triethylammonium bicarbonate (2 x lOml) and water 
(lOmi) before being dried (anhydrous sodium sulphate). The solvent was removed 
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under vacuum and the product was purified by silica-gel flash chromatography, eluting 
with methanol in dichloromethane (0-5%) + 1% triethylamine to give a waxy, white 
solid. 
Yield 0.15g (48%). Rf 0.32 (system F). 1Jmax(fium)/cm' 3338 (m, OH), 2955 
(s), 2930 (s), 2840 (rn), 1704 (s), 1508 (s), 1384 (m), 1253 (s), 1182 (m), 1095 (m), 
1034 (m). FAB mass spectrum: m/z 899 (Mt). 'H-NMR (CDC13): 8 0.96-1.02 (t. 
9H, 3CH2 Eth, J=7.2Hz); 1.40-1.69 (m, IOH, 2, 2', biotin 6, 7, 8 CH2); 2.47-2.53 (q, 
6H, 3CH2 Eth, .1=6.5Hz); 2.67-2.71 (m, 8H, 3, 3', biotin 2, 9 CH2); 3.31 (m, 1H, 
biotin 5 CH): 3.52-3.60 (m, 4H, 1, 1' CH',); 3.78 (s, 6H, 20CH3); 4.20-4.26 (m, 2H, 
biotin 3, 4 CH): 6.78-7.68(111, 17H, AM). 31P-NMR (CDC13): ö -5.63 (s). 
[55] 
DMTr—N SS OTBDMS 
H 
Compound [50] (leq., 0.50g, 1.69mmoI) was dissolved in anyhydrous pyridine 
(lOml) to which was added 4,4'-dimethoxytrityl chloride (1.2eq., 2.03mmol, 0.69g). 
After stirring at room temperature for 16 hours, the reaction was incomplete and a 
further 0. 17g (0.50mmol) of 4,4'-dimethoxytrityl chloride were added and the reaction 
mixture stirred for a further 16 hours. All starting material having reacted, the solvent 
was removed under vacuum and the residue was coevaporated twice with toluene. 
Without further work-up, the product was purified by silica-gel flash chromatography, 
eluting with methanol in dichloromethane (0-5%) primed with 1% triethylamine to 
give a yellow oil. 
Yield 0.53g (52%). Rf 0.86 (system E). umax(film)Icm 3498 (w, NH), 2954 
(s), 2928 (s), 2854 (s), 1607 (s), 1581 (w), 1507 (s), 1463 (s), 1442 (m), 1298 (m), 
1249 (s), 1212 (w), 1176 (s), 1098 (s), 1035 (s), 946 (m), 910 (w), 832 (s), 776 (s), 
702 (m), 664 (w). FAB mass spectrum: m/z 596.26990 [calc. for C33H46NO3S2Si 
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(M + 1): 596.268841. 'H-NMR (CDCI3): ö 0.06 (s, 6H, 2CH3); 0.89 (s, 9H, 
3CH3); 1.83-1.93 (m, 4H, 2, 2' CH2); 2.19-2.25 (m, 2H. 1' CH2); 2.72-2.82 (m, 4H, 
3, 3' CH2); 3.67-3.73 (ni, 2H, I CH2): 3.78 (s, 6H, 20CH3); 6.78-6.85, 7.16-7.48 (m, 
13H, ArH). 13C-NMR (CDCI3): 8 -5.43 (2C1-l2Si); 18.17 (C); 25.80 (3CH3); 30.39 
(CH2); 31.97 (CH2); 35.19 (CH2S); 36.77 (CH2S); 42.23 (CH2N); 55.02 (20CH3); 
61.04 (CH20); 69.70 (C); 112.75 (4ArCH); 125.95 (ArCH); 128.25 (2ArCH); 128.99 
(2ArCH); 129.51 (4ArCH); 138.37 (2ArCH); 146.48 (ArC); 157.61 (2ArC). 
1 '_(4,4'_Diniethoxytritylanhino)dithiOdiprOPafl-1-OI [56] 
DMTr N 	 S - S 	 OH 
H 
Compound [55] (0.21(,, 0.35niniol) was dissolved in teabuty1ammonium 
fluoride in tetrahydrofuran (1 .OM, Siiil) and stirred at room temperature for 16 hours. 
The solvent was removed by evaporation and the residue was coevaporated twice with 
toluene. Without any further work-up, the product was purified by silica-gel flash 
chromatography, eluting with methanol in dichloromethane (0-5%) primed with 1% 
niethylamine to give a yellow gum. 
Yield 73mg (43%). Rf 0.36 (system E). umax(film)/cm' 3409 (s, OH), 2949 
(s), 2928 (s), 2835 (s), 1606 (s), 1580 (m), 1506 (s), 1443 (m), 1298 (m), 1248 (s), 
1177 (s), 1033 (s), 828 (m), 701 (m). FAB mass spectrum: m/z 485.20484 [caic. for 
C27H35NO3S2 (M + 2): 485.20584]. 'H-NMR (CDC13): ö 1.80-1.97 (m, 4H, 2, 2' 
CH2); 2.17-2.23 (m, 2H, 1' CH7); 2.60-2.84 (m, 4H, 3, 3' CH2); 3.48-3.59 (m, 2H, 1 
CH2); 3.77 (s, 6H, 20CH3); 6.75-6.84, 7.14-7.46 (m, 13H, ArH). 13C-NMR 
(CDC13): 6 30.31 (CH2); 31.72 (CH-)); 35.11 (CH2S); 36.80 (CH2S); 42.20 (CH2N); 
55.05 (20CH3); 60.88 (CH7O); 69.71 (C); 112.92 (4ArCH); 125.96 (ArCH); 128.24 
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(2ArCH); 128.99 (2ArCH); 129.51 (4ArCH); 138.36 (2ArCH); 146.46 (ArC); 157.61 
(2ArCH). 




DMTr - 	 S - S 	 0 - 
H I - +b 
0 Et3N H 
Compound [56] (leq., 92nig. 0. l9mmol) was dissolved in anhydrous 
tetrahydrofuran (8m1) to which was added 2-chlorophenyldichiorophosphate (1 .5eq., 
0.29mmol, 70mg, 46ji1) and anhydrous triethyamine (3eq., 0.57mmol, 58mg, 79.i1). 
The reaction mixture was stirred for 2 hours at room temperature, then quenched with 
aqueous l.OM triethylammonium bicarbonate (lOmi) and stirred for a further 2 hours 
at room temperature. Dichioromethatic (15m1) was added and the organic layer was 
again washed with aqueous 1.OM trierhylammoiiium bicarbonate (2 x lOmi) and water 
(lOmi). After drying (anhydrous sodium sulphate), the solvent was removed under 
vacuum and the product was purified by silica-gel flash chromatography, eluting with 
methanol in dichioromethane (0-5%) + 1% triethylamine, to give a yellow oil. 
Yield 65mg (44%). Rf 0.29 (system F). umax(film)/cm' 3402 (s, OH), 2963 
(s), 2930 (s), 2836 (m), 2629 (m), 2492 (m), 1648 (m), 1585 (s), 1506 (s), 1444 (s), 
1363 (w), 1247 (s), 1177 (m), 1094 (s), 1033 (s), 902 (m), 829 (m). 756 (m). FAB 
mass spectrum: m/z 673 (Mt). 1H-NMR (CDC13): 8  1.21-1.27 (t, 9H, 3CH3 Eth, 
J=7.3Hz); 1.80 (iii, 2H, 2 CH,?); 1.95 (m, 2H, 2' CH7); 2.14 2.20 (m, 2H, 1' CH2); 
2.66-2.75 (rn, 4H, 3, 3' CH); 2.91-3.00 (q, 6H, 3CH7 Eth, J=6.4Hz); 3.75 (s, 6H, 
20CH3); 4.04-4.06 (m, 2H, 1 CH-)); 6.74-7.64 (m, 17H, ArH). 13C-NMR (CDC13): 
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Appendix : Anti-HIV Oligonucleotides Synthesised 
SRev : d(TCG TCG CTG TCT CCG CTT CTT CCT GCC A) 
SRandom : d(CTG GTC TCG TTC CCC TCT CIT CTC CCG A) 
SdC28 : d(CCC CCC CCC CCC CCC CCC CCC CCC CCC C) 
C35-C6-SRev 	Cl 6-SRev 	Chol-C6-SRev 	HEG-SRev 
C35-C6-S Random 	C 16-S Random 	Chol-C6-S Random 
C35-C6-SdC28 	Cl 6-SdC28 	Cho]-C6-SdC28 
ChoI-C(-S S-S Rev 
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